-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 PT5/I0GOhimoQX7tvyQT7kQTr/NCYqS8eU2G3EQskluT03IrJB7VjwPkg1XiNNNm
 B/kGyv7Is2vJ+m4bC3O0eA==

<SEC-DOCUMENT>0001167379-08-000112.txt : 20081224
<SEC-HEADER>0001167379-08-000112.hdr.sgml : 20081224
<ACCEPTANCE-DATETIME>20081224105619
ACCESSION NUMBER:		0001167379-08-000112
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20081223
FILED AS OF DATE:		20081224
DATE AS OF CHANGE:		20081224

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALCON INC
		CENTRAL INDEX KEY:			0001167379
		STANDARD INDUSTRIAL CLASSIFICATION:	OPHTHALMIC GOODS [3851]
		IRS NUMBER:				980205094
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31269
		FILM NUMBER:		081269375

	BUSINESS ADDRESS:	
		STREET 1:		6201 SOUTH FREEWAY
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76134
		BUSINESS PHONE:		8175686248

	MAIL ADDRESS:	
		STREET 1:		BOSCH 69 6331 HUNENBERG
		CITY:			SWITZERLAND
		STATE:			V8
		ZIP:			0000
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>acl6k1208acrosof.htm
<TEXT>
<html>
  <head>
    <title>acl6k1208acrosof.htm</title>
<!-- Licensed to: Alcon Labs-->
<!-- Document Created using EDGARizer 4.0.6.3 -->
<!-- Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved -->
</head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">UNITED
STATES</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">SECURITIES
AND EXCHANGE COMMISSION</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Washington,
D.C. 20549</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 16pt; FONT-FAMILY: Times New Roman">Form
6-K</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES
EXCHANGE ACT OF 1934</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">For the
month of <font style="DISPLAY: inline; FONT-WEIGHT: bold">December
2008</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Commission
File Number 001-31269</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 16pt; FONT-FAMILY: Times New Roman">ALCON,
INC.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">(Translation
of registrant's name into English)</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">B&#246;sch
69</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">P.O. Box
62</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">6331
H&#252;nenberg, Switzerland</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">&#160;41-41-785-8888</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">(Address
of principal executive offices)</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Indicate
by check mark whether the registrant files or will file annual reports under
cover Form 20-F or Form 40-F.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td align="left" valign="top" width="11%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Form
      20-F</font></div>
            </td>
            <td valign="top" width="2%" style="BORDER-TOP: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid; BORDER-BOTTOM: black 2px solid">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">x</font></div>
            </td>
            <td align="left" valign="top" width="9%" style="BORDER-LEFT: black 0.5pt solid">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Form
      40-F</font></div>
            </td>
            <td valign="top" width="2%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-TOP: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b) (1): ____</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b) (7): ____</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Indicate
by check mark whether the registrant by furnishing the information contained in
this Form is also thereby furnishing the information to the Commission pursuant
to Rule 12g3-2(b) under the Securities Exchange Act of 1934.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td align="right" valign="top" width="11%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Yes</font></div>
            </td>
            <td valign="top" width="2%" style="BORDER-TOP: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="right" valign="top" width="9%" style="BORDER-LEFT: black 0.5pt solid">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">No</font></div>
            </td>
            <td valign="top" width="2%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-TOP: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid; BORDER-BOTTOM: black 2px solid">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">x</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">If "Yes"
is marked, indicate below the file number assigned to the registrant in
connection with Rule 12g3-2(b): 82- ______</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div><br>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
      </div>
    </div><br>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Attached
as Exhibit 99.1 is the Press Release issued by Alcon, Inc. on December 23,
2008.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">SIGNATURES</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="21%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="14%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" colspan="2" valign="top" width="49%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Alcon,
      Inc.</font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="21%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="14%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" valign="top" width="19%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">(Registrant)</font></div>
            </td>
            <td valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="21%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="14%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="21%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="14%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td align="right" valign="top" width="16%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Date</font></div>
            </td>
            <td align="left" valign="top" width="21%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;
      December 24, 2008</font></div>
            </td>
            <td align="right" valign="top" width="14%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">By</font></div>
            </td>
            <td align="left" colspan="2" valign="top" width="49%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;
      /s/ Elaine Whitbeck</font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="21%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="14%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" colspan="2" valign="top" width="49%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;
      Elaine Whitbeck</font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="21%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="14%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" colspan="2" valign="top" width="49%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;
      Corporate Secretary and General Counsel</font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="21%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="14%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="21%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="14%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
  </body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>acl6k1208acrosofex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<html>
  <head>
    <title>acl6k1208acrosofex991.htm</title>
<!-- Licensed to: Alcon Labs-->
<!-- Document Created using EDGARizer 4.0.6.3 -->
<!-- Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved -->
</head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
    <div><br>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 396pt"></font>Exhibit 99.1</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right" align="left"><img src="acl6k1208acrosofex9910.jpg" alt=""></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">FDA Approves Alcon&#8217;s
AcrySof</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 70%; VERTICAL-ALIGN: super">&#174;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> IQ ReSTOR</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 70%; VERTICAL-ALIGN: super">&#174;</font>
<font style="DISPLAY: inline; FONT-WEIGHT: bold">+ 3.0 D</font> <font style="DISPLAY: inline; FONT-WEIGHT: bold">Intraocular Lens</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">New
lens corrects for cataracts with presbyopia</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">HUENENBERG, Switzerland</font> <font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8211; December 23, 2008 &#8211; </font>Alcon,
Inc. (NYSE: ACL), the world&#8217;s leader in <font style="DISPLAY: inline; TEXT-DECORATION: underline">eye care</font> and <font style="DISPLAY: inline; TEXT-DECORATION: underline">cataract surgery</font>
announced that the U.S. Food and Drug Administration (FDA) approved its +3.0
diopter add power AcrySof<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">&#174;</font> IQ
ReSTOR<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">&#174;</font> IOL.
This new lens, which was introduced in many major markets outside the United
States earlier this year, is now approved in the U.S. for <font style="DISPLAY: inline; TEXT-DECORATION: underline">cataract surgery</font> in
patients with presbyopia. This lens is another technology advancement for the
AcrySof<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">&#174;</font> IQ
ReSTOR<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">&#174;</font>
platform, which has been the number one choice of surgeons to correct presbyopia
in cataract patients&#160;since it was introduced in 2005.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>&#8220;The introduction of this lens allows
me to deliver a full range of quality vision for my patients&#8217; needs, lifestyles
and personal preferences.&#160;&#160;In my experience, the AcrySof<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">&#174;</font> IQ
ReSTOR<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">&#174;</font> +3.0 D
add IOL gives my patients a more comfortable reading distance, improved
intermediate vision for tasks such as computer work and excellent distance
vision,&#8221; said study investigator, Kerry Solomon, M.D., Professor of
Ophthalmology, Medical University of South Carolina and Medical Director at the
Storm Eye Institute. &#8220;In addition, the lens does so with the same accurate and
predictable outcomes I have come to expect from the AcrySof<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">&#174;</font> IQ lens
platform.&#8221;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">The US
clinical trials included a three-month follow-up exam of near, intermediate and
distance visual acuities. The percentage of patients who achieved 20/20 or
better at all three distances with the AcrySof<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">&#174;</font> IQ
ReSTOR<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">&#174;</font> +3.0 D
was nearly fourfold the rate of patients who received the control lens,
AcrySof<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">&#174;</font> IQ
ReSTOR<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">&#174;</font> +4.0 D.
The clinical studies also showed a high rate of patient satisfaction with over
95 percent of patients stating that they would have this lens implanted
again.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>&#8220;Advanced technology IOLs that correct
for presbyopia and astigmatism are the fastest growing IOL segment of cataract
surgery.&#160;&#160;The addition of this new lens meets a growing desire on the
part of cataract patients for spectacle independence after cataract
surgery.&#160;&#160;With the availability of the AcrySof<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">&#174;</font> IQ
ReSTOR<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">&#174;</font>+3.0 D
lens, surgeons can deliver true performance at all distances for their cataract
patients,&#8221; said Kevin Buehler, senior vice president, global markets and chief
marketing officer.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"># #
#</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">-more-</font></div><br>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160;
</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        </div>
      </div><br>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">About
AcrySof<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super; FONT-FAMILY: Times New Roman">&#174;</font>
Intraocular Lenses</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Alcon&#8217;s
<font style="DISPLAY: inline; TEXT-DECORATION: underline">AcrySof</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super; TEXT-DECORATION: underline">&#174;</font><font style="DISPLAY: inline; TEXT-DECORATION: underline"> intraocular lenses</font>
are the most frequently implanted lenses in the world, with more than 35 million
implants since their introduction in the early 1990s.&#160;&#160;Alcon&#8217;s
AcrySof<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">&#174;</font> IOLs
offer cataract patients a variety of benefits that give cataract patients a full
range of quality vision.&#160;&#160;The AcrySof<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">&#174;</font> IQ,
AcrySof<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">&#174;</font> Toric
and AcrySof<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">&#174;</font> IQ
ReSTOR<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">&#174;</font> IOLs are
part of Alcon&#8217;s AcrySof<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">&#174;</font> product
portfolio.&#160;&#160;&#160;Since the introduction of the Acrysof<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">&#174;</font>
ReSTOR<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">&#174;</font>
platform, Alcon has accounted for more than half of all presbyopia correcting
lenses implanted. For more information visit <font style="DISPLAY: inline; TEXT-DECORATION: underline">www.acrysofrestor.com</font>.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">About
Cataract Surgery</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">A
cataract is a &#8220;clouding&#8221; of the eye&#8217;s natural lens, which results in blurred or
defocused vision.&#160;&#160;IOLs are implanted during <font style="DISPLAY: inline; TEXT-DECORATION: underline">cataract surgery</font> to
replace the patient&#8217;s natural lens that has been removed during surgery.
Cataracts cannot be prevented and are the leading cause of treatable blindness
worldwide.&#160;&#160;For more information visit <font style="DISPLAY: inline; TEXT-DECORATION: underline">www.cataractsurgery.com</font>.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">About
Alcon</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Alcon,
Inc. is the world&#8217;s leading <font style="DISPLAY: inline; TEXT-DECORATION: underline">eye care</font> company,
with sales of approximately $5.6 billion in 2007. &#160;Alcon, which has been
dedicated to the ophthalmic industry for 60 years, researches, develops,
manufactures and markets pharmaceuticals, surgical equipment and devices,
contact lens care solutions and other vision care products that treat diseases,
disorders and other conditions of the eye. Alcon&#8217;s majority shareholder is
Nestl&#233;,&#160;S.A., the world&#8217;s largest food company. For more information visit
<font style="DISPLAY: inline; TEXT-DECORATION: underline">www.alcon.com</font>.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Caution Concerning Forward-Looking
Statements. </font>This press release may contain forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of
1995.&#160;&#160;Any forward- looking statements reflect the views of our
management as of the date of this press release with respect to future events
and are based on assumptions and subject to risks and uncertainties. Given these
uncertainties, you should not place undue reliance on these forward-looking
statements. Except to the extent required under the federal securities laws and
the rules and regulations promulgated by the Securities and Exchange Commission,
we undertake no obligation to publicly update or revise any of these
forward-looking statements, whether to reflect new information or future events
or circumstances or otherwise.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Media
Inquiries&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Investor
Inquiries</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Holly
Clark&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Doug
MacHatton</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">800-631-0962&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;800-400-8599</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="TEXT-DECORATION: underline">holly.clark@alconlabs.com</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
<font style="TEXT-DECORATION: underline">doug.machatton@alconlabs.com</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">www.alcon.com</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div><br></div>
  </body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>acl6k1208acrosofex9910.jpg
<TEXT>
begin 644 acl6k1208acrosofex9910.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"``Z`.<#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`HH
MK!\8>(HO#'ANZU%R/-"[(4/\3GH/ZU=.G*I-0CNQ2:BKLYSQQ\4+3PO<'3[&
M%;S40,NI;"1?4^OM7%Z?\<-6CN0;_3K>:W)^81$JP'M7F%Q<2W=S+<3N7FE8
MN['J2>IJ*OM:.386%/DG&[ZL\B>+J.5T[(^N=$UJR\0:5#J.GR^9!*./53W!
M'8BM"O!/@[XI_LS6GT2YDQ;7QS$2>%E'^(_E7O=?*YAA'A:[I].GH>E0J^TA
MS!117FGQHOKNQ\.V#VES-`[76"T3E21M/I6&&H.O6C23M<NI/DBY=CTNBODA
MO$6M;3_Q-[WI_P`]V_QKZ;\&RR3^#M)EED:21K9"S,<DG'>NW'Y7+!P4G*]S
M&AB%5;21N4445Y9TA1110`4444`%%%%`!1110`4444`%%%%``2`,DX`J*"ZM
M[H,;>>*4*<-Y;AL'WQ6'XO9OL-I%([QV4MRJ7;J<83!P">P+;0?K7)^'_MEO
MJFFF6%+:[DE5?*A0*)(BA+E@.,`XY/2NNEA>>DYW,Y3L['IM%%%<AH%%%%`!
M7SS\6O%/]N>(O[-MY,V5@2O!X>3N?PZ?G7K7Q#\4+X7\+S31L/MD^8K<?[1[
M_@.:^8RS,Q9B2S'))ZD^M?2Y!@[MXB731?JSS\;5LO9H3Z#\*V]?\,W_`(<3
M3VO5P+V`3)@?=]5/N*UOAKX9/B3Q7#YJ$V=IB:8XX./NK^)_E7M7Q%\+KXE\
M*311(#=VP\ZW('.1U7\1_2O3Q>9QH8F%'H]_*^QSTL,YTW+[CYGBED@E2:%R
MLD;!D8=01R#7U+X)\21^*/#-M?@CSP/+G7/W7'7\^M?+!!!(8$$'!'O7??"C
MQ3_8/B465Q)BROR$;)X63^$_TI9Q@_K%#FC\4=?\PPE7DG9[,^BJ\M^.7_(L
MZ=_U]_\`LIKU*O+?CE_R+.G?]??_`+*:^8RK_?*?J>CB?X4CP@]#]*^JO!/_
M`").C_\`7JG\J^53T/TKW/6O%4_AGX2:,+-]E[=P)%&W=!CEA_GO7T>=495X
MTZ<-V_T.'!R4.:3['H6H^(]&T@[=0U.UMV_NR2`'\JP)OBKX/A;!U3=_N1,W
M\A7S9+))/*TLTCR2.<L[G)8_6FJI8X52Q]%&:RI\/44O?DW^'^94L=-OW4?1
MZ_%SP<QQ_:$H^MN_^%;&G>.O#.JR+':ZQ;&1C@([;2?P-?++)(@^>-U'NI%3
MV%A<ZG?P65G$9;B9@J*/6G/(,-RW4FON_P`A1QM2]FC[`!!&1R*J:AJ=CI5L
M;B_NXK:$?QRL%%9_A?29O#WAFVL;R]DNI84S)+(<X]A["OG3QMXFNO$_B.YN
M)96-M%(8[>+/RJH.,X]3UKQ,#EWUNM*"E[L>IV5J_LHIM:L]NN/BWX0MV*B_
MDE(_YYPL1^>*I'XT>&`?NW9'KY5?/J(TCA$5F8\!5&2:T5\/ZTZ[ETB^(]1`
MU>[_`&'@X?$W]YQ?7*KV1[O#\8_"4G^LGN8O]Z`G^5=!H_C3P]KL@CL-4@DE
M/2-CM8_@:^7;FQN[)@+JUF@)Z"5"O\ZA1FC<.C%74Y5E."#4SR##27[N37XC
M6-J)^\CZXU?6;#0K`WVI7`@MPP4N1W/2L#_A9WA'_H+Q_P#?)_PKSK5?$D_B
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M`#DDTM<%\5?%7_"/^&S:6\FV^O@8TP>43^)OZ5MAZ$J]6-..[)G-0BY,\D^)
M/B@^)?%,IA<FRM,PP#L<'YF_$_RKCJ*U-%\.ZMXAEEBTJS>Y:)0S[2`%';DU
M^@TX4\-24;VBCPI.525^K.F\&_$8>#M*>TM](CGDE??),9,%O0=.@KH_^%ZW
M?_0$B_[_`!_PKC_^%9^,/^@++_W\7_&C_A6?C#_H"R_]_%_QKSZE#+:LW.;B
MV_[W_!.B,\1%62?W&%K6H0ZKK%U?P6JVB3OO,*MD*3UQ5`$JP*DJP.01V-=4
M_P`-O%\<;.VBRX49.'4_UKE2""0000<$'UKT:-2E*/+2DFEV=SGFI)WDK'TU
M\.O%`\3^%H99&!O+;$-P/<=#^(KF_CE_R+.G?]??_LIKSGX;>*#X9\4Q&9\6
M5WB&<=AZ-^!KT7XXD'PQIQ!R#=<$=_E-?-/!_5LTAR_#)W7^1Z'M?:8=]T>$
MGH?I7H'Q`E)\+>#8NPLBWYXKS\]#]*](\?V3GP+X/O@#Y:VWE,?<@$?R->]B
M6E7HW[O\F<=/X)GG**9)%0'!9@/SKZI\,^&-*T#2+>"SM(@_E@O*5!=SCDDU
M\J]\@\]J]IT+XUV,.EPP:M8W'VF)`C/"`ROCOCM7#G6'Q%:$515UU7Y&N#G"
M#?,>JW>FV-_;/;W5I#-"XP4=`17,^$?A[IGA/4+V]A_?33.?)9QS#'_='^-8
M4WQO\/*A,5G?NW8,@7]<US.L?&_4KF-H]*T^*TR,"25M[#W`Z5XE#+\P<73B
MFHO>[.R=>@GS-ZH]:US6+2WBN-/\Y?MLEK+(D0Y.T*>3Z5\GCIFO2?AA+>Z]
MXSU&XO)I+F>2RD#R.<]>!7G=S;O:7<UM(,20R-&P]P<5[V5X986<Z-[NT6_Q
M.+$U'4BI>IZO\#;&VGO-6NY85>>$1I&S#.T'.<?D*]MP!7S%X%\;3>"]0GE%
ML+FVN%`ECW;3D="#7HX^.>E[1G2;L'N-XKR\UR_%5L2YPC=.WY'3AJ].--)N
MS.S\=V%M?>"]42XB5PD#.I(Y5AR"*^61]T'VKU;Q5\8AK.B7&FZ=IKP&X78\
MTK@X7O@#O7E/2O4R;#5L/2E&JK79S8NI"<DXG9::3_PJ37N?^8C!_*N.KN;*
MT>'X+ZI<L,)/J,6TGOMX-<+7=AFG*I;^;]$8U=%'T/H/X1:!86OA&#4_(1[R
M[+,TK+DA0<!1Z#BO1/+C_N+^5<A\+/\`DG6E_P"ZW_H1KL:^'Q\Y2Q-1R?5G
ML44E35CY[^,MA:V/B^![6!(C/;AY`@P&;)&:X[PV2OBC2B#S]KB_]"%=U\</
M^1KL?^O3_P!F-<)X=_Y&?2O^ON+_`-"%?88%MX"+?\IY5;2N_4^MJ***^#/:
M$)P,U\_^-M`\9>*?$US?'0;S[.I\NW4[>$'X]^M?0-%=N"QLL)-SC%-^9E5I
M*JK-GRY_PKSQ?_T`+K_QW_&O<_AOX5;POX8CCN8PM_<GS;CU4]E_`5V%%;XS
M-JV*I^SDDEY&=+#0I2YD%%%%>6=(5X+X_P#AMJX\4SW.AZ;)<V=U^]Q%C$;'
MJ/ZU[U179@L;4PDW.&MS*K2C55I'R[_PKOQ?_P!`&Z_\=_QKN-?TKQ9K_P`.
M=*L+C1;HZC97.QU.,M&%(5NOX5[517=4SNK4E&4H*\7=;_YF,<)&*:3>I\N'
MX=^+\'_B07?3_9_QKW:T\+1:O\.K+0]7A:)Q;(K#^*)P."/<5UM%8XO-JV)4
M;I+E=U8NEAH4[VUN?.>L?"+Q-ILS?9(4U"#/RO$V&(]U/2L";P5XF@;$FAW@
M/^YG^5?5=%=5/B#$15I13,I8&FWHSY/7PGXA<X71KTGI_JC6C:?#CQ;>2*JZ
M--&&_CE(51]>:^GZ*N7$-9_#!?B)8"'5G$_#OP(/!UE-+<R+-J%SCS&3[J*/
MX16'X^^%+:Y?R:MHLD<5W)S-!)PLA]0>QKU*BO+CF&(C7==/WF=#H0<.2VA\
MPS?#7Q?#(4_L6:3'\4;*0?UJ!OA_XM7KH-W^0_QKZEHKTEQ#7ZQ7X_YF'U&G
MW9\NK\._%[8QH-T/KM_QK?T7X.>(;^=#J)BL+;/S$MN?'H`*^@Z*FIG^)DK1
M20XX*FGJ>?>.?"DB?#5-"T"R>8PR1[(DQN(!Y)KQ[_A7GB[_`*`%W_X[_C7U
M%16&$SBMAH."2=W?6_4NKA85'=G+_#S3[O2O`^GV=]`\%S&K!XWZCYC74445
MYM6HZM251]7<Z(KE21XY\6O"VNZYXCM+C2],FNHDMMC.F,`[CQR:X_0_`7BJ
MVU_3IYM#N4BCN8W=CM^4!@2>M?2=%>I1SFM2HJBHJR5NO^9S3PD)3YVPHHHK
%QSJ/_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>4
<FILENAME>acl6k1208acrosof.pdf
<DESCRIPTION>PDF
<TEXT>
<PDF>
begin 644 acl6k1208acrosof.pdf
M)5!$1BTQ+C$-"@T*-2`P(&]B:@T*/#P-"B]%(#,W-38-"B]((%L@,3`X.2`Q
M-#D@70T*+TP@-3,W-0T*+TQI;F5A<FEZ960@,0T*+TX@,@T*+T\@.`T*+U0@
M-3(R-0T*/CX@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@#0IE;F1O8FH-
M"@T*>')E9@T*-2`W#0HP,#`P,#`P,#$R(#`P,#`P(&X-"C`P,#`P,#`Y-C8@
M,#`P,#`@;@T*,#`P,#`P,3`X.2`P,#`P,"!N#0HP,#`P,#`Q,C,Y(#`P,#`P
M(&X-"C`P,#`P,#$T-3@@,#`P,#`@;@T*,#`P,#`P,34V-B`P,#`P,"!N#0HP
M,#`P,#`Q-C<V(#`P,#`P(&X-"G1R86EL97(-"CP\#0HO04)#<&1F(#8Q,3(-
M"B])1"!;(#PP-45!1#4Y-$,U-S8W-3`W,D9$1CA#-4$Q,#%#.#<Q,3X-"CPV
M,35&038S,C,Y,#,W13E",C=&,T,U-S0R14,X.#DQ1#X@70T*+TQE;F=T:"`P
M#0HO4')E=B`U,C$U#0HO4F]O="`V(#`@4@T*+U-I>F4@,3(-"B]4>7!E("]8
M4F5F#0H^/B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`T*
M<W1A<G1X<F5F#0HP#0HE)45/1@T*-B`P(&]B:@T*/#P-"B]/<&5N06-T:6]N
M(%L@."`P(%(-"B]&:70@70T*+T]U=&QI;F5S(#,@,"!2#0HO4&%G94UO9&4@
M+U5S94YO;F4-"B]086=E<R`T(#`@4@T*+U1Y<&4@+T-A=&%L;V<-"CX^#0IE
M;F1O8FH-"@T*-R`P(&]B:@T*/#P-"B]&:6QT97(@+T9L871E1&5C;V1E#0HO
M3&5N9W1H(#4X#0HO4R`V.`T*/CX-"G-T<F5A;0T*>)QC8&!@8F!@<6)08&!@
MM061<*``A2D,8#4@P#*#`04@\UD<0004,S#D@,W*ATH"];-O`3$``"P$[@T*
M96YD<W1R96%M#0H-"F5N9&]B:@T*#0H@."`P(&]B:@T*/#P-"B]#;VYT96YT
M<R!;(#$Q(#`@4B!=#0HO365D:6%";W@@6R`P(#`@-C$R(#<Y,B!=#0HO4&%R
M96YT(#0@,"!2#0HO4F5S;W5R8V5S(#P\#0HO1F]N="`\/`T*+T9A8F,Q(#$P
M(#`@4@T*+T9A8F,T(#D@,"!2#0H^/@T*+U!R;V-3970@6R`O4$1&#0HO5&5X
M=`T*+TEM86=E0@T*+TEM86=E0PT*+TEM86=E22!=#0H^/@T*+U1Y<&4@+U!A
M9V4-"CX^#0IE;F1O8FH-"@T*.2`P(&]B:@T*/#P-"B]"87-E1F]N="`O5&EM
M97,M0F]L9`T*+T5N8V]D:6YG("]7:6Y!;G-I16YC;V1I;F<-"B]3=6)T>7!E
M("]4>7!E,0T*+U1Y<&4@+T9O;G0-"CX^#0IE;F1O8FH-"@T*,3`@,"!O8FH-
M"CP\#0HO0F%S949O;G0@+U1I;65S+5)O;6%N#0HO16YC;V1I;F<@+U=I;D%N
M<VE%;F-O9&EN9PT*+U-U8G1Y<&4@+U1Y<&4Q#0HO5'EP92`O1F]N=`T*/CX-
M"F5N9&]B:@T*#0HQ,2`P(&]B:@T*/#P-"B]&:6QT97(@+T9L871E1&5C;V1E
M#0HO3&5N9W1H(#$Y.3,-"CX^#0IS=')E86T-"GB<U5I;=^)&$G[G'/Y#G;PL
MFS/1]OV2-X^-9\@%9@%O)B?>!XQET`:$@T0\R:_?ZI9:@&T4>QAQ=H]G[`*Z
MN[ZJ_NK2+=Y^;+=^:[=(I*C6!HC[*66F(JV$$,!()(U2&J;+=HL!5R+B2ED*
MEA`PW,(Z;K=^@K3=HN!^UC,WC.T-L]Q$BG-2#+[S2NO'^`7?CMNM?UQ.;J8"
MJ((QSO,(O0KJ)0K<XF\J*(P1GM41L=9*&/_IK*)NUD.[U;GJ]\;="QB-S\;=
MT=]A_)]VJXMK__-+`F&&(1!6`/D&E6O%<.S4`RED!V74/;\:]L:][@C.^A?0
M_7C^_JS_K@OG@Q]_[(U&O4&_(7Q<X^Y04CE*6F5$Z2AB%>4%OI\FV3Q)9_DJ
M?0,7T7F$^R^%/0Z3<\JSF`310(FT'A/"T$1XCZ'[.'.R0W2Y6B]!-85`\ST$
M",@!Z'S3E#Y#=O4IQ0I]WQ^C#S>6'])G=SS<@8:X19T3&0G48MQ27<4@$26U
MAMT/@^$8!I=P.1AV>^_Z\&'8^Q>&)"#QK[I#^'`U'%V=]<<P'L#PZH<NKCMI
M"+%$=FTA\\@(7D;#L5M?H])N5;H$P4Q(#TYR'L*Y@R%0>=L4!$-/;K51^]PP
M"JM+R0TNE:HLO^I?(`?&[[NPDR.K_-@0/$$DPB,E/(59D>""`9[B);RS<\];
M:KDX,E`/AA`#JW@!@T6:&,Y+&-P88ZM4"/D\AN4JS>>PNFLLGC%\`QID*F%"
MZ9*KI>S07,33>'D3K[%$$-.@6USI+/C*#)>!/$R90)[SU7*99%FR2N$R6<30
MWWA8A-"F4%E1P<(DKMD7*!HUZIB;6JKK<,K44?6XIEHPL:/H2'(=+('(9S`N
M[10)07.MBHAS.1&M8V7(_7`^Z+^!7O\\:LBMG"(05X`=$"04I\J&F+-$EU7K
MFD@R7D_2;#')'<,PZM;Q+,ER?"__6P;I9!E#DN8KZ*:S19+-<4)3O!.,@V$R
M)"O!C*SJ++XHP^'M-2K*IG,XFB<'<2"##)';2N8."J&6>=GA^!`-(GB[^@2*
M-;6#N'O:R)`>-&-:A?0@*2FS)BY,X?TUUR*-4TP,LS<P>DCR/^/U8I(>56KK
MH&'CI54!K7.-@24:(P7=:CI!,G(<K`QKSB@\6)[2*"&W1B&CFE*C3FN5WK$*
MNXACB_2ALB')#M>/*AMU`<4%:%'&.HWPQ%J=,3BC4FZS]=GM[3K.,I>I[]=)
M.DWN)PN(/\7339[\'N/;=\DTSAI,T]BT8`,7>CF&12VTE"B)LM?OI;?)=)+'
M</,'3.?Q]%=83M:_PL,\Q@ZO:/.V=0;NL*]!B];PD"P6_A5,TG2#AJWC^]4Z
MSV"3WN*TZ>IW_.V/S(PT9)ZTIK+O!"Q6>%2KW*FQ-%L26F,\6U:W!,XYWF[1
ME-W*Z)/:;?F..B)+=9?'MD.'HE@35>EK+(HQ-!2G(8CQ?*5"P<;XEKPV-)*[
MQU&19)!M;I9)GB?IS']X_&51;4T7%?I3I&^<6CF+8Y9CBE>''QVZF^^Q^83[
MR3V&_20#_./<$=\ZWPWCV:;L6H^Z]:PCJ6"G=(G"[%FY1$;$,LM"+K`J7*.,
M8;C!!$D)=>7@QF5Z<))[2;^%:\KU[O^FXLG*"FN3\22M^#^.IX#^1/%4.>M_
M.)Y.Z!(73Y5+7AU/^N3Q%+`V&D_N3%U<"6C#JMM`;F0XV+ZN=<-!=YMUFOCG
M*O[#)+W#L"J(-%VE^21)D6!(NWR.$>A##O].%MG*#5_']2OD?E23#N$Z]+)2
M\HH@S&HCGES`W6_6V<:9C;`*UK`9;^I>#(^B`=PIKN&8W?J"1T91&^Z+F)"R
MO+=BVQ@I6G*W.2,\?*R3/,$>OOMI.I^DLQC.IKD[HK@[Y:9:.LEHA;C)D!&*
MA!*$.=U4-]="N%M`'S)W\-7/<?:5([8+EOCV#9(XA%&\6#UX/_F#35I<WTZ0
M4#,7&"7!=^N4CYLTGOH`>$CR>>-<4]Q69IXD,<NM5V4D.6>!:U2;<`._Y=JW
M8)JZ9%.8<T]HN<:I05WG26UINL9(MJ/\L1)W>,&60>!!"3//J\\]FH:+6[21
M5U]2X#Z-5$^ZGQ[;CU"K9*6V;NN.T("K;S70\OE]Y_(+:C"DTO!H2[9C!;6X
MOH2E$XU7M2A%H[QH'HFR&&"#.&^W[K[>6](4ZSQ>LE`4UE&[DW_;?JXL;N0K
MVU/I#"VX9W14\*/SZ1F+A^\<X;]KMWZ!?^/+6X\%)Z`I4>&#XJ7BD8<W*J`9
MZZW@G+]Z#_S<E_'WZ?7+,8JE8"]B\'$ZS(LX?)0.;"K_DL4&5RU9;!@+E/-B
M05UC=T0:J.NG'6!Q&+8,XM-U]A7MBJ):O:"Y7^$QX\/GRAQD_*%LZZ=J$9I+
M3G3Y`,X_,'DN_0I$^SDYQ)\TMT_YA>*D:&,[V)34Y!2!\\H$X%27.472*@'L
MB2)DB%)\-J>X=1XO62A:A`'B:4YQ;];DE(-?_W%@"'^1A^MS"YJTFUN$.PSL
MYQ9GS>>$AL&M"'N#G30KPZ^_JHF2<E\<34LG.K'<#$?I2J1A,]RT0_L2ABV#
M^'2=/45[(@^KEQOG5GBRA^'SFB@YZ!_IIMK:NE!$ASN;&?<%,_&\AD-/Y/W4
M<(QRCY>G-2'(M?DL):Z\<<-?J@63SV=K4?8OM>"_[L=VJ]WZ+[W8X4L-"F5N
M9'-T<F5A;0T*#0IE;F1O8FH-"@T*,2`P(&]B:@T*/#P-"B]#;VYT96YT<R!;
M(#(@,"!2(%T-"B]-961I84)O>"!;(#`@,"`V,3(@-SDR(%T-"B]087)E;G0@
M-"`P(%(-"B]297-O=7)C97,@/#P-"B]&;VYT(#P\#0HO1F%B8S$@.2`P(%(-
M"B]&86)C."`Q,"`P(%(-"CX^#0HO4')O8U-E="!;("]01$8-"B]497AT#0HO
M26UA9V5"#0HO26UA9V5##0HO26UA9V5)(%T-"CX^#0HO5'EP92`O4&%G90T*
M/CX-"F5N9&]B:@T*#0HR(#`@;V)J#0H\/`T*+T9I;'1E<B`O1FQA=&5$96-O
M9&4-"B],96YG=&@@,3`S-PT*/CX-"G-T<F5A;0T*>)RUF$USVS80AN^<X7_`
MT9UQ:7P1'T>[43.Y=%);F>30"T7!%EN9:D!R4N?7=[&D+$\C*03<C'R@!"X>
M[+XO@:5O/N79YSRCA6):&T+#9[KFJM!*2DDX+4JCE";U8YYQH@PMA%*6$4LI
M*;D@WN791]+F&2/AXQ_P-DWQ!B7$='NX[1YQ.,DXRE^.XB0WRSR[^K5:U88P
M0980@:O":1E>`803QF!I2UB1Y86@6EFR_)IG%W]P27\BRS_S;`'S_/X_X<H#
M[H(D3Z_.9<.G;"04FVI,AA:<*0W77P![W?=5O7%K4G5D\<^F634]L;9@I.E(
MOW'DO7==1V[=UE6=@Q^[`>Y=/9'K;;UK+\F[MB[(KB5O7.T>5\X3+BY!66J*
MM'38Z70DA4$*\H=\?H8D:+BUAASNWKW][7KYX79Q]R-J:`W?&P+BIQJR0DAI
MIQJ^'WPW5&U/^AW6S+O/0^/=HVO[CNSN\;<[5P^^Z1L7REQOJO;!D>NZ#\/,
M"GDY!3XT7>_#5!O08SULGTA=#1V4O-^`(-[]O?.(63G2-0\M#$#Q&\"LW*;:
MW@=EPD0_I`YJJ@,K+&-:35X27)1BK,/0KIT?EX7Y>#>TL%9,HQKZS<XW7]TZ
MT1EGGB,N]?/JOGV.\#$PAAB`,'E\9G9B9F,L#%J!4X/ERM%P83<XQK%4``(6
M1*/W'<OXB6WG6Q#4&TFFC">%V/DH(<R(@NTX%H6Q\U%2,41)<:)^Y[8&C#4C
MJBPD-=9,]F1&*#EM=8<MZXAVQB1K9VR4=DA*U"X"%>J/J$3M(E"A_HB"T_P4
MZIQVQIC]UE(:J<R$HB6]?=X1X1O[+U?Q,46N9'2*&!LA',@,"PL.@6,[VB$Z
MSB&!!`Z))H78^2A4.:#`(;$HC)V/0I4#"AP2B\+8^2@45ADT12P*8R.T`F5+
MD6R*4D>9HA3IIIB/0F%+D6Z*^2@4MA3IIIB/0F%+D6Z*"*U`67'^+#G=94F(
MG?9"55#*Z-AF7;RI>G?4%.+\67*2A+$321=:*FJG$Y-:;*R_[/,[M/9R;.V/
M.D:</VA.[O[R1<:LH+*4?,SXYNFH7<29#N%[I\R>PPNI2IAD:F`I$_9%OE?=
M%5ELJZ9UY..FZ5>N_NN8Q"R]7>!QAP%[1;LP'X4JLE>T"_-1*`9[A9#L(*34
MX(B]D#PT\L]"?E]$;=-%I%$B(BE5Q/FH(`2B4D6<CPI"!%2JB-H>^G5H^<1S
MO\Z9>"'B+SL/[[RP^X4W:._ZRL.[9+LF;UWK?+6%\:'MW/:8N#JY7=,F3ER=
MWJY%H%!<G=ZN1:!0()W>KD6@PNDZ_E\P[62.T0J45<GMFE91[1J24DTQ'X7"
MJO1V+0*%PJKT=BT"A<*J]'9M+@K^%I_R+,_^!:,JH!L-"F5N9'-T<F5A;0T*
M#0IE;F1O8FH-"@T*,R`P(&]B:@T*/#P-"B]4>7!E("]/=71L:6YE<PT*/CX-
M"F5N9&]B:@T*#0HT(#`@;V)J#0H\/`T*+T-O=6YT(#(-"B]+:61S(%L@."`P
M(%(@,2`P(%(@70T*+U1Y<&4@+U!A9V5S#0H^/@T*96YD;V)J#0H-"GAR968-
M"C`@-0T*,#`P,#`P,#`P,"`V-34S-2!F#0HP,#`P,#`S-S4V(#`P,#`P(&X-
M"C`P,#`P,#,Y-S0@,#`P,#`@;@T*,#`P,#`P-3`Y-R`P,#`P,"!N#0HP,#`P
M,#`U,30Q(#`P,#`P(&X-"G1R86EL97(-"CP\#0HO4VEZ92`U#0H^/@T*<W1A
4<G1X<F5F#0HQ.#,-"B4E14]&#0H_
`
end
</PDF>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>acl6k1208acrosofex991.pdf
<DESCRIPTION>PDF PRESS RELEASE
<TEXT>
<PDF>
begin 644 acl6k1208acrosofex991.pdf
M)5!$1BTQ+C(-"@T*-2`P(&]B:@T*/#P-"B]%(#(W,C$X#0HO2"!;(#$Q-3`@
M,34Y(%T-"B],(#,P.#8W#0HO3&EN96%R:7IE9"`Q#0HO3B`R#0HO3R`X#0HO
M5"`S,#<Q-PT*/CX@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@#0IE;F1O8FH-
M"@T*>')E9@T*-2`Q,`T*,#`P,#`P,#`Q,B`P,#`P,"!N#0HP,#`P,#`Q,#(W
M(#`P,#`P(&X-"C`P,#`P,#$Q-3`@,#`P,#`@;@T*,#`P,#`P,3,Q,"`P,#`P
M,"!N#0HP,#`P,#`Q-3DQ(#`P,#`P(&X-"C`P,#`P,#$V.3D@,#`P,#`@;@T*
M,#`P,#`P,3@P.2`P,#`P,"!N#0HP,#`P,#`Q.3(P(#`P,#`P(&X-"C`P,#`P
M,#(P,S4@,#`P,#`@;@T*,#`P,#`R-#(W-"`P,#`P,"!N#0IT<F%I;&5R#0H\
M/`T*+T%"0W!D9B`V,3$R#0HO240@6R`\,T%$,S4U-3=!13`R0D0P1$-"-D(R
M.3$Y,S=&1D,T.44^#0H\1C@Q13(W,41#0C,S-D8V,C)&.#(Q-3$X,#1&-$(T
M1#<^(%T-"B],96YG=&@@,`T*+U!R978@,S`W,#<-"B]2;V]T(#8@,"!2#0HO
M4VEZ92`Q-0T*+U1Y<&4@+UA2968-"CX^("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`-"G-T87)T>')E9@T*,`T*)25%3T8-"C8@,"!O8FH-
M"CP\#0HO3W!E;D%C=&EO;B!;(#@@,"!2#0HO1FET(%T-"B]/=71L:6YE<R`S
M(#`@4@T*+U!A9V5-;V1E("]5<V5.;VYE#0HO4&%G97,@-"`P(%(-"B]4>7!E
M("]#871A;&]G#0H^/@T*96YD;V)J#0H-"C<@,"!O8FH-"CP\#0HO1FEL=&5R
M("]&;&%T941E8V]D90T*+TQE;F=T:"`V.`T*+U,@-C@-"CX^#0IS=')E86T-
M"GB<8V!@8&)@8*EG4&!@X-4&D7"@`(4I0#8K1"B"DP$%(/-9ZH`$.Q0S,.2`
MS5H+E03:P<`,D0LK9F#@%@$)`@!$G@5F#0IE;F1S=')E86T-"@T*96YD;V)J
M#0H-"B`X(#`@;V)J#0H\/`T*+T-O;G1E;G1S(%L@,30@,"!2(%T-"B]-961I
M84)O>"!;(#`@,"`V,3(@-SDR(%T-"B]087)E;G0@-"`P(%(-"B]297-O=7)C
M97,@/#P-"B]&;VYT(#P\#0HO1F%B8S$@,3`@,"!2#0HO1F%B8S(@,3$@,"!2
M#0HO1F%B8S,@,3(@,"!2#0HO1F%B8S0@.2`P(%(-"CX^#0HO4')O8U-E="!;
M("]01$8-"B]497AT#0HO26UA9V5"#0HO26UA9V5##0HO26UA9V5)(%T-"B]8
M3V)J96-T(#P\#0HO26%B8S0@,3,@,"!2#0H^/@T*/CX-"B]4>7!E("]086=E
M#0H^/@T*96YD;V)J#0H-"CD@,"!O8FH-"CP\#0HO0F%S949O;G0@+U1I;65S
M+4)O;&0-"B]%;F-O9&EN9R`O5VEN06YS:45N8V]D:6YG#0HO4W5B='EP92`O
M5'EP93$-"B]4>7!E("]&;VYT#0H^/@T*96YD;V)J#0H-"C$P(#`@;V)J#0H\
M/`T*+T)A<V5&;VYT("]4:6UE<RU2;VUA;@T*+T5N8V]D:6YG("]7:6Y!;G-I
M16YC;V1I;F<-"B]3=6)T>7!E("]4>7!E,0T*+U1Y<&4@+T9O;G0-"CX^#0IE
M;F1O8FH-"@T*,3$@,"!O8FH-"CP\#0HO0F%S949O;G0@+U1I;65S+4ET86QI
M8PT*+T5N8V]D:6YG("]7:6Y!;G-I16YC;V1I;F<-"B]3=6)T>7!E("]4>7!E
M,0T*+U1Y<&4@+T9O;G0-"CX^#0IE;F1O8FH-"@T*,3(@,"!O8FH-"CP\#0HO
M0F%S949O;G0@+U1I;65S+4)O;&1)=&%L:6,-"B]%;F-O9&EN9R`O5VEN06YS
M:45N8V]D:6YG#0HO4W5B='EP92`O5'EP93$-"B]4>7!E("]&;VYT#0H^/@T*
M96YD;V)J#0H-"C$S(#`@;V)J#0H\/`T*+T)I='-097)#;VUP;VYE;G0@.`T*
M+T-O;&]R4W!A8V4@+T1E=FEC95)'0@T*+T9I;'1E<B`O1FQA=&5$96-O9&4-
M"B](96EG:'0@-3@-"B],96YG=&@@,C(P-#D-"B]3=6)T>7!E("]);6%G90T*
M+U1Y<&4@+UA/8FIE8W0-"B]7:61T:"`R,S$-"CX^#0IS=')E86T-"GB<['UG
M>%O'L?:B`VR2++E753;T#A8UR]UICIWF),Y-'*<ZR4U\$R>V<Y.XQ$F<Q"GN
MMBQ9LKI(2>R]%Q`$2(`@V*LHJI$4*XB^W\P>@*0<^WNN$_WT>=8P1((XY^R^
M._/.[#M[*/V81YC2"&LT'*&^"/6&J"]$`T$:#E(:6M&X3X5#-((?]E%Z*4S/
M!2*GPW224F_0'\$/!2@-LE?\ZTN4CD?H`*7G\"_A!WX:\M(@_"G^PXM?$F$7
M$&*O^)\WPAK[_B#^(/9;.&F(-3P[=R(??B&\AQ_"_Q=96Z!A[L=XC9'8W[+S
M+>*O@J&/VS^?'/_?(Q3D^IJR/@[2B#_:XV$:6*3>>?QM)`J>0)CZN9'^3X_(
MTDD!M($((A9!&T)X?A"Q'!("@9#//\?@/1^DBT'N<L,(B(4%&O#3"(-*,.B?
MGAVC=`)0#;?F6Z#>6?91N!W_PD>`UL=`Z^-P'_TMFU:1R/*5X$^XJ1%8QJ2/
MAA=I<!'G1##(W=?2-[._]3'01JY(IWURQ(Y(##P<8B/0QY%`M/-CK_#_0,@?
MC"Q&N`&[`F==F@L<:+D69/]<@56Z=&T,7A$ZYPOYT++1F0CUC-+Z=EI42_.K
M:%T;[1ZGYQ?I+/LM3*V%@!=N+1*FWH7H)7L79Z-&>0F64=!&S_X!Q-*8U0SA
MF;G?AFDHC/8\$N"@'J3S?M:"^,\`?B`<G2,<T(,(YD]`>\4/;I!P%,(1;RB\
M$&;&UK<8BH1CJ`J&0Q%_",?%=\5`2Y=`&UQJ#)@K#\Z@!D)A'^*',8FS<[2Y
MB[YVQ/OX[_KN?J1JVY?*=SQ<^NGO53_R5,-3KW7GMM`1'P7_X&?N.\B9RC!.
MNMBW78[,R%(/+'&1E=0%C#_8=K##\U$K':4(<S!OH(7H3!#;7"AJPX-XLNAY
MX$1!]@W!*]-IGQS18\GG^1BU6X@@1PMR'CG"6B#,&1SPPUYO:/J*&(V8(0U_
ML*TT^YS[92T4"OC`EH7IQ05ZI)1^]C';==K#LK3C,D4!/^T$/_VH0+&/+W\]
MR?QFQK<J?O37?L\XG0_3Z0`].Q-F8`UZ_;-1&_M!Q*ZXI@\B&:;(?(1>"K$&
M9IZQ"*ZO`+%`JB]]&&B#C+6P-Y'`,I_XY+AB!V=CO5SCJ%V$$4N_G_H"V!;\
MU(_&`SP=`&?A"H$VYG"7OBVR$BW+\XBU8)!=UO`%^M=W)S(_6Y:8FD,VEI'-
M36)C-]&W$X.5;ZKCZ8J)\JA`?_S:[&,__-^!MGX$UD0(0R%PW_.!:7;&%;;T
M7PUL>.45<5$;T)#)"'[-I2#U^ED\Q[X%.PU<CY\&&&NEP9516"@&VG"`+E'E
M3XXK=H27L,$AE@N%T,8%HS[;SU'$"`P`1/>!*P%:CA($Z!**EJT<NM28@>40
MB\0`K/_(%/WG^Y/I.PZ0:]Y*4+=>M^N2-'."J`:)IH<8W"3#+<SL$)I;B;*>
M;,Z_*GG_3W\WZAJG4Q18;GB:3OC03@8O.]&'7\#*L'2>Y2(FF;&=Y[CT+/NI
M/^8&%M@_.2+MX[XU'`LC8]277BE.]<D1/;@P9#%,%QG[8ED:<'A>M*ZSB_B&
M([(`F[D@F*P/<,Y_\Z1<Y$57FKYH"Z\8:,Z`H7^?IO25P].&3Q^-2]DC4]3$
M&?J)]@Q1CA+M"#$-$0O@MH/HW1)C?[QA)$G3E;2E_&;MX=^\/C@:Q+^=H7-^
M-A^7SQ4UYE$BM#+DC+6HI67-RY)744X`;3:"#:PP3(J+["=3[(<^%JC%P!^-
M%*Y8(/#)$3VBOCB\A%B@@@OT_!0]<+3CSW\O_^NKU=6-%RYY<<B64Y'_\4DC
M2T.YA*)HFB@8\4.,X_/[YA;]8/G1X,\&:7D[S?A"B3CYK749=0)E"TES";/.
M$L,@,?40LYN8@"&T\[5NL;)/ECZ:D#9\M;KG*GF!YC,'J_H15#,T/,<E2Y>Y
MP3)H8[@-T^5T`8U$?1#&7Z%0"#YW?HZ^>V+\0#D]4$$/E-##\%I&]Y;2O65T
M7R7=!^\+9M_/&[LXA]!=#$21'\2WOD^R!U?ZB`X6)F%#:&#KK),_?^;HCW]^
M[*=/GOK%KPN>>C;_G?=;A\\C;B\MTBN1)P]'5J8[E_TIC9G9Q5`D"'!%9A*F
MHU/T)W^\>,O."F%:WBJ+G:]U$5T7+VN0J!S$#,U&3%:>WB;2N&2*OH2TL<34
ML83T06E:S8U9[__\E<Y!/YK!&<ZL7P[:"$,R`VV0T1(:BD6`H26V'PD"8;HT
M1_,JY[=^;G?*CO=OS#BP>?OAY)W'-^T\==L.:/D;=IU:OV/_^LR7/_/-_656
MW]0B\EWXDH4@(!8Z]8IPJD^.Y2,,XP9TUAM9]&.:J,4Q\_@3[SW]N_+:%EIM
MI:X^>C1OYML_W//L2WDS`<33%0'M<KXT$@-*B'$#1F47?#,A1K+G@Y@$R*NG
MFW952+7U`E6C6-_.T[7S+6Y^IHNH:XFYGIAJ><9:H:Y)JG;$*SH3TP83TD:E
MBF&)JBW)D"/_S+[\#G3?\YB#6/+]T>P$%W(RT`;8?.$6T#C*BA<9],V@"X*Y
M'*2GRFG:UG<3TO:+TG)7:?-7Z4L2M952395,6QMOJ$K0'D]0O+H^XZ4#)7.7
M,/K#+YD/0""+*:]/0'ME#\PEX7H36H1Y/_W]2X6//;Z_M(Z^^+?!M_;-OWMH
M\<BIP'O'SG[_?_:5U)V="UXIT*[(E\:RI\S68?"U&/)&HYX(=0[0'_QF0"(O
M%NL\`ET'4;<1O8-GLA-3,[$T<HCE&^I%NB:QQBY3N>(575+%`%\U+-!Z$DPU
M<:HWGGQU:-B+H`5>NX()+-O5F*6-@C9&IMG,PO4N3)WX`_14%=V<?31>5036
M7J2J$6D:A6H[3^DD*J=`8Q>J2D6I>]/NVI=;3Z<CR\$:(-8?]'["::_P$8FN
M[,/@='3[_NN[KYXL61R^0.]]Z.!O_S3Z_2>L+[\Q[NRGWWWBT.XCKL7(%0$M
MO8P8+(&6<<C%\`P,]TP8'?I4F+YUU"_?=4JB;!(;AWG:3J)QB,R`VT:BJ95F
MMO+U37R]E:^S\W4.H;:=:T!NB7Z0J#U2DUTD/ZZ\/R>OB4XR/\((.<<$\'S+
MH`VS""K"J058JGJ)TP;](1]=\-'#)?1&XT&24BC4VL4&N]CD$ADA`!S@&4:$
MYGZ)P2I5Y:3?<SBWCDX&*-Q#;'D\'`HN?@+:*WV$O5Y?A"6AW+V!![_ZI_9>
MVM9'/_7EW&=>'/WFXXU_>>-\YS!]ZH7R4Y7GSLY<(=`N!>S!6.8)N8$W%)F>
M"T[Y6*8)B*CG/'WT%YVK4P\*E0ZB`1QV"O6NN"RG$$"KJI$86X5:!U!<OJ:3
MZ#J)WDV,#F($BFLGV<-$VRTT=B7HFP2WO?[$BT.>T270!IA=C6H#.&*R%'WY
M+P,MRQX$Y@&TX(YRJ^F&G2>%FFH!A'[Z5F)H(X9>HAW`#(:^GZ^QP@39N&/?
M\1K,*OBC&ILPMRYV1<+73X[8$0X&O-SB*8S+P&GZ^:^_=*1@P7.:/O"-XE__
MZ>RC/[;N/AKHOT!__FSQ6X=<%^:O'&B7B`'7T/H!AYT"&CO/XJ:16?KW]^<U
M=YY,2CLI5+J(JI]HW&!1Q?IFB:%9K&L1J!Q"=0]?#6`>)=IA8NPBEG:2U4BR
MFLCV/F+L`S.XQM(EWG#$<'?NX;PI7Q2TWI6@]2^!EEG?%:`-LK7:27P-8QKP
M8!F](>L@2<\GR@9B:N%9(`;LQ@R&<91G&A+I6R7*W-0[#N76(@\/<DX$D]TA
MEK"](KWVR<$=X5!HGL71F#TX,T%?>JW^E\_5-G;0Y_Y^H:R%[LVE1XKH[F.3
M#WWSU7TGNQ>N3"`6&\.5T,7O!5@A:,<7?&!F[6/T4X_9XK;L2U17"_5NGK%7
M9/(0A94DU\3KVE=9>@3*3J&*0^PHT0\3$P-M9A/)M!(CV-X>HO7$6SK7Z.OY
M-_[]9\]V=XT@)I>->PRT2^PV\J^6-GB11N8I"PGWE49NWGE$;*H59'J(KAF-
MK<Y--!ZB[2%ZX"W-)/UX^GTG#I;0LY=0(+=\7^'PROSOAP/XLM^NU),%5_"G
MR]>[(Q_RMTLINQ4RN0\N]7V\0;KLJL(?>?V7'Z%H^F69^4567DQX^?J61727
M'9??YF42D6C/^/SS@4`H%*&+(7IV@G[C>WN>^7UK;CFU=M-&%]UWTO>5[[WW
MXFO58/W.7`EZ$%H.=EC6:VE\,"^/H)T%,[M(_WF"KM67".6U/*V=:!N)`7$B
MTCEEZLXX5;=$T2M0]!%YM\`R0HR]1.?B9?>1##?1M@@M740WPC,,$S/\845\
MEE68GG]K9O$;Q^ALF$ZRS`38\GF,\J/)YZ4>6LH>1).Z$)V%<4;#;#U436_9
M<9BGJB7Z;J)W\8QNOA;H@8<8'`2LKJF5:(HWW%UPI!H7OO%V_-&\-I)E?SCZ
MI:'HN<(!7!*.A);&)Q)=6PEQRRNSL76-.>35D04@<6RY.!#-SD7"T>6W"%!F
MW](WAV(K0?/<:ETXX(\L+O?WRG6<)3!\X)\,]Y%@C/L'N!D=HB$_7G2(2=["
M$4Z7PJ$M$HZ]1P5<R!_DEK8#OM!D,#2%)C$2`0+*.H#=`F<:O/B6J9%Q@1PO
M/A`%YZ)W%L\-'11:NF;&LE`8/4.#L]Z%N:BO9%\*W6AKF?W=\Z4__D7QLW]V
M/_5BZW=_<>*ONYOZ)[`?YB/A*P+:11I>@`B'R[J'5H)V&I`\36EE%]WYC>Y$
MK95L:42S"?"S@/VT(3U0=4J5?3+ED%@]R--V\2S=_*V])+.+&`!(+HFY0ZSS
MD-1>OG90F`W,LTR4U<)7U\4IJK[PX_&V05SY0]E:8)SBVRBR8LMA0:8D#"\+
M";"[``AX[U'0`C?0]0.%%A@\`DT_3PV@M9(,*V:,M16WW5UZN)H-04PNSAGS
MZ'Q8BCH_8'4Y,\(M8>,T\4<BWC"><S$F78BAE/N38"CD\X?]@>4OX=1L,=`N
ML+88G33<$LD\T_:&N#L-A5;:\,M%(/3RRXOB&2:8%U]C$0C@D(&7M1#3600C
M2]:>>:M`=-ZQM$QLVK`K60)M,+H('F(=L+C`W5$0L<A)C\(Q[3UV:8BMCD;E
M*)S5#2YZN<D`/YB=I0X7/5X\?K3XC',(JP7FHA^]`LNX(51->Q=Q;,/+:U,A
MUC-T'NYF?)$^_\Z"=,L1J<9&U#9B[B26;F+I0&NF;Q%HVD1JMT3;(]5U2XTN
MDMY`-#8,CK0=1-LN-#F(SDY2W3Q-CR#30?35P#]%IE9^2MGUAE/_.+#`+;8N
M+%Z(2G&6C>K'`2W0E670VDA&"S&U$4W5AKM*CU2AC`8[F8TP`ZT_Y)^E/C`1
M"YA#BSE]-"TA/VN+P<AB.+*T>(WC'V#Y'&AA)@=!.(<NL]78CX&8AI_+,T<N
M<Q:8"?'[`O[Y2`!./4U#<S2T&`D'PQ$($^?"="H0F?2%+H(]#$0N<4(U7V36
M3P$ZN+`38KW!3A[P!R<#X0O!R&0(HTRNS`1_Y0=VN>3<\7["<-WP!Z@+Q;$%
M[S!/%[UP/[@6'_+-TTL!>I%";RPN(OD*PF5=G*(7EV-AO-^`W^?%R88`6<%U
MPLNRD/G@Q870A0CGAFC`.[^PZ`UQ$W9\!F4J2W-V88'Z?5<@HHA@G<&,C\X%
ME]/\4<0"8"XNTMH.>OO#3>+D?)Z\.6%;-R[1F@:(J9\E!ZQ()K5M0HU+K'/$
M&QH2S0T238-(W1)O[A,8W$1=SS>WBHW=/$T',=B)#C#6(C([19I&T9:##WRO
MR=;+4=;0DAIGR9[\6Z"%R[-C4&9R$G75QCM+CU5!+\5P$XBP&>I#P(3G8HK<
MZ**&__+FB]'IQ4CL#=?".,N@`2*\3'JW/(Q8"A2."=*\2XM^D:7_1:VW;Z61
M#$7P-OTX"O"*>I*EV>*CEYUZR6+[8E?(R9@PZ1U!E,\$Z%P`E1E^3G3!89<B
MB4`]7(AQ()@'@25S#__V1KL?%VW"LW02VF+(AY]GX/(!6/V+W.4'6`E6B$W>
M9>T6,^->NN#%^!CG1B#("1&7KW\N')GSQ6BU;PGM_PEHX>LF@C!GE\(&_$[H
M`S2S?>?I_[QX=IW\Q&J=C<BMTJU@0NU$-40TP\381BS-N&YK``+9PE=52U4Y
M#_Q\YO['9Z\Q6A-U[CA3-]'527:T)VSM1!.M8E;:X"3Z-IFY7:PHO"WSV&__
M>7J"]>%B`!DC)D]"_P9H7<3H1M"J>G&%#A!KZ"2JFLUWEAZO8N.%W0W]B+JX
M11KEHJ&@W^\/>OV1A5`4$ER>!.C0I0@N2<S$N"R7\>,:$_Q$U64<4P4SM(B2
M2"\3-$UA3RYKU&,5%AP]7FHQQPT&',X.)`RH_2R--OB*L1GL^8&+M/<\]8S1
M]A':-DR=(]0U1CO/T)ZS^-OA*3H^3\':3E]^57-1\H$T%"",>GMN3B*8@IS1
M7V#W<H&]XAHWFS!P)9,T-(E!`#B`$+/>`5_8R^94%'[>".J5I]E)9[F^HM$+
MF&8J_(4@QF(+84S:@#^;0Q3!Y/9&8R8.Z%<@30[V;0*'**:3898';&\0KJK4
M1N7;2Q)3*N(T#B"H0`EX\"H?(8I1%O(TDXQ6\/A$5R]4%UR;=7!_-3U>3S,^
M[Q9N+!>HX%=-)*M%DF'C:ZQ$V2;=-L;+'"!*.\_8SE=5QBMSMGVIHL[#`("Y
MOCGTJJ'PQP.MOA>,/S&Y`+0"%9!GE]#80?0>HJS=<D=I3B7K\0`3<H;0F@%[
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M,,E+<_F"G_9=H`,3.'VJG32_B>;6!W,;`[E6;'O*ID_9:*V'-GNHLX^>GF2Z
MN]@<G$.SP6G_6;GJPA4!;8!-E_D5,;O/QVHHW6/TOY^[<%5JP6J-0Z!LD6:Z
MB;E-8.D1RD\+%2,(%0C'+.T0]?",]?&&G"_]O+7M#+T8H$_^86Y5:C[94L7/
ML!-#/=&62\TM1.X66<[R,L>(R@D8(YH&B;KZ>LNII_]Q>O@2CB`+S%F(&OJ8
MH`6BPH%6V<_7NH7&3KZNFZ>H3]Y5>J*28AD;@A;C(A\S"`O,'`'S`;18^VA^
M<W!/L>\?QP/?_G7O5_^G_U/?[<O^@EMQMWU]9N/UVMJK5:7K-"?7:8]!NUIW
M]'ICSDV6W`W9IS9O.W'7([;/?[_]Q\^._65O>'\A+6A$8PCXO^!#R:\WFI`,
M8)H.V$A@'GT:"ZZ!74S[:<\XK;31`T6A1W[:?=\W/;I[JF\S'K].>6"=_,!:
M^9$UBJ/7:/+7J0O6J@I7*PI6R8L3L94FI)>ND==<I:A=JZI:IRF[1EMTK2'W
M>M/A&\V[C9\]?N^W\W_P7--?]@_FUBTX1G`VX3R:9X,\[^=L76'1V4>?K/GR
M+QV?^[GC@?]Q?ODGGJ\]WO]?WQ]ZY(?]7_YIVU=^UO"U'YQZ]B^.CD%<`SV[
M2)VGZ<$2^LI!_WW?*-OZ8)%\5\XMY@/7&_9=HW]OK?[=J[3OWI1Y8O/.4L6=
MY?J[R^[Z4NV/GAYX]:#_1"U._S-^G,Z+7%@?1F?'JE[_<]0&H_D.+I)%BP`4
M'1W'D4JZ,:/T*I4U4>T2:%N(NI&7Y2$0=JF'):I!\/(8BYDZ"'!42]VZC(/[
M*\)]$ZA=S*NDFCLKA,D%LFU@G,'&%B9M=9`T-U&.$/,8T74)MO6!H>:K6X5I
M>9:'2L"FH9\%9Q)APH)_`[3F=@ZT0HU;9.@2:+L%\BAH@URHRZ)+.,L$Q4BC
M?9CNS??^^(76.Q[.2=[YSK7ZUU>I=J_2'$M0YDGD):+4*E%J@R2M-4[A3%!U
M2)0VL:)1)&\2IC>*TQJE\N9X97.BNCDAO28NM3@IM7"MHN!&;;[^GN;O/.5]
MXQ@=G*%G%M&'QA+1<V@6`+K,C8#W')^C%0[ZFW\,9SUP,"GYI:M4N0!%64I1
M7%K9*E7M*DUCO`K.7@\GBE.VQJG;$K0=<1JW5.46*CKXZ1UB>1<TD=PEDK>)
MY%:AO%8L+Y,H\L6I!^/2WTU2O'&-_E7M?0<??=JUOXQVCM-I;\S8@HM>H']\
MN76M_`\D^76Q_IA8EY^H+%F37GUU<L/5*?5KY&57*8_%W?K2E[[O:!^EXP%Z
MJIG^\-GS&[./)B;OOE9?>)6J)#ZU3)I6$Z=HD"GK!>G5)+E"++<+DVVB+76K
MTJI@CM^@.7FS_M!Z\YXO_[3U'T<7/.<1MQ`,8CIB<9I&YC@)WW]T1-<4,-D5
M083,S5/_N2#U3-!/?[OG)HB>;JT2J]L3MK4#!R#J=MG6<9+<EF3NYQE=1.L@
M.@\_HXNDG_CBK[J[)YD[\-.)>?K#_QU8JSU)5'40&4DRZWCZ&J+JX1O.\2SC
MQ-#'6*A+H.]:;6F+2]O[XQ>[IQBQ#RP$/S:G!=":[.@"M+U"9;](W2G1=XDT
MW3"4BKLKCI;$Q@LZ;`'-;/<L_=O[]'./SERG*(_?=&JMHC))62%35L3IZ@3J
M*KZFBJ^KAJOE&:J(OI+HRXBNBF@;^'J;P-@F,KO$YDZ1R2/4NT7:#H'*(=.W
MR]36>%7=:G5-?%IQ0FK>S:83#S_A*+;3Z3#217;,A0/G41K)<HCG`_3=0KKS
MX:JK=>_';=F[2ET0IZZ2ZJT27;-`U2C2-,N,;1)#.T]E$QMA`G;R]9TH\]!W
M\PP]`N.`R#R$6E!##]_8RS-T,06(BZ=Q"K7M$JT#IJI449>DK8?9E)!:H+[/
M\\U?7NP819(Y,X=&#AC*"__H2I"_(3&6$E,CS'>8YC)%7V+J*#1X$Z^RBS8<
M>^!'$\5N^H>#-/V^QG6&0F'*B37&AGB53:;NE*H'T&II3XMT(P+ML$`[QM=.
M"=071>HA^&VBUI:HKDV0E\6!@U;FWV`\^>`/.D[48)Z"36$O<^N!*P!:;E@1
M#V#LIF;8_AKO%-)-V;9$N9N?;!?IVJ395F2P*"KH%VN=JS(\?+V3*!SBS!&2
M6G/KG57_S(U<B*DEYP.TW$;-#U2+TDO!1$O,-7P@"1#::\#,#A)M%X+6X.09
M^XG"QD_)S?IR14Z-?XXE&)>"P?\S:+N)R;82M%)=EUCC`="FW5&<6X5A+9=Y
M!N<,+/2IU\?2[^Q8D]XM6F]/E'>N-0S$:6#2M1&%'8(X3(88K4C%+0TDHY9D
MU?"RZHFY&7V*N1V3$@8(15U$[2+*#J+U\(W=`K63K[3%Z>Q2=:-,47>UL>Q:
M[3N?>;3@4,'$Y#P7*,^Q&`7X`1T/TK\=\^L>+`.KR-M2`.%MDL%%Y$TPM6%&
M,`5%&]_4@8&#SHD%(,#/X8QZIN70=6#_X]G;L&G:B<:)/P'HF@>$EA&^81`Z
M6:3IC3/TB^6=9(-5)G>MW^[XX?-#K<-1LCT3H']\>WRUX1#15A,XHZF'Z`=X
MZE&1XJQ8?IZO&A.JNT2*VEMVV3_S/Z&4S[K)YD-2?1E,YWAS&T_91I0]//4P
MT9PANG&B'R>ZTUBTHIDBZ@D"`#9XI*:V.*--BKWAB%-UBE.:;K8T?^'Q@;UY
M0?`OF.X(3T;+`_]#T`88ST.$S$]%9B8IM9^EG_UACW!#M22]3PK\4`LTH):?
MV8*9+J5'I&^1&($MM)-4^YKL07+;\8=^VMT^QI)T;'G+SXI?GOS+V*KT$Q)5
MO<A8(S1;!?H>5"PH>\`X(ZDPNH29PR2U1:IMO$I[]-M/.08O(MF+A#^NI>5`
M:X?!$BGZQ6JW5-\IUG2*Y56;=N87-M.)2RR?$Z!3"_3IUWMNN?UMLND@V50!
M1DFB;15B,L1.M.W$"(R]BY@\#"0`#Q>^@C<!H%ILV#+:248'`;>2T4<R!HAE
MB&C["-@]K8>HVJ5&=[S1)5/;DK259.WOT[:^\O:AL45./1?&?,)\A(XNTM)N
M:OIZ!;GU;9)<3M+:$O2G19I^Q*&E@V=Q(VBAJZ'I'#!]^)D=O"PW/[N3:R2S
M@UB<,'=$V[OAYW@Q1DR;X#4;NW$A$GH8#(*N1VP<E)J&`'XDM9VDE*TU[WOZ
M]9$Q%IU=6*0OO3>99#A"U-7LCCJQV,30B?<"3=<%M"UQAXVORU^SLY:HCI&T
M@ZONJ!-F5!)S#8%!-T$(`W.D!QJ>%SH'+L`PP/R=@V0T"K)JQ)D-(G.;2-\K
MUITCR0"/EH24HOL?;2QQL.6-L/\*:`_"+.$.7X?>PP<.]'2(_OEPZ!IS(1`5
MF69$`KVAMN(]FEHP0PMCI$'1+%_EDFH]">K&V[**WCJ!B1H63'GG%T<A2`9<
MU;JIZ?ZJ->I*GK:*9W&(3;T\#>`67%L7'P8(8C$`B=J9:/$(4PM4]Q8<+L.%
M7?_'S=->!MI>`*U,UR'6`O&KV+CC),2YLRRVFYRBAPMHYE?R2>HK,D-Q0J8U
M(:M58&Q"`J-N)D:G(+,;K9FA"X<>F@XX3#\V@X=HFXBNCNC@M8490`].7A.K
MX@30PGAI.F2F3IG1*50TR11%F[*._/QY3^\8!NOA8"@4F@W1X%2(MH[1[_ZY
M3Z1]G\C+UNP\(]*/D90!HAKB6P:9V@=LN!,9EP&0V0&(9:=K)GHK+IIC:V0-
MWK00"#$T\%L;,;8CZLP>A!!GC=7P)2Y11G?"U@&9I4N@:^`KCVJ_D'^X%C4D
M0,->VCLM3-]/]/4(VDP7@6#9;&=9=P<2+9.5E]%$E$7\S&IB*";&(NF.6J(K
M(;I*5I;2!GV%,3CP1KV-&)J(OAF1C_AO()GEO.P27A;[I*Z'J,_SE),BQ1C9
M5'V-X?`3?^EQ7Z"S]#^WLU%+ZYO&HALOQ<7I^F&Z_1M-@N2\>&T71#=$`UW!
M60!@L)U(94WU?(M5H.Q89^B6;CST[5_TC$P@?XM$5]2`U<[AQAF4_O8O$^O-
MQ41>@3E_HQOHF4C;*39ZA#A#'41C%61T"@W=,-:K%"<?^46?ZPQ6Q7]LT!HY
MT'8#:*7`NO7M8FV;4%&RY<Z\]\LP80C$8&"$/O+CME7:`T)]/E]7+K8T2S);
M>68KSV039+C0@FDYGPL&MA.</DPQ:#!AD5B:6H5&*Q_L#(Z4DV&[!YO&P[?T
M"TS=P"M$6AN1U_#3*M89\W_R[)"]BY5F0)_X%RAF@G&P3CGH;7<?(2DY,.Y\
MXXC`,$8V.F6F,:(?0ORK`77=(DN?)+-?FM$CR7"++2Z)Q2$UV:3F%IFI.<[2
M%)_1'&]I`=(KU3LE!J<(IHD)6%8[!L5P`7`7EG8$N;H&9ID@HUF4T4AT%1)S
MG53S_L__T=,_C0F!/[\[)T[9+S984:21Z4!14T8]\EMH9N!"30A+70<,#8-Q
M"R)0VRS-[A*8@0YU023"UWD$!C><76)I%V7"%&O#<-M<06"L,XM(1CG^4P\.
M:)3(QZ3&BW%ZMV#+`<UG<M_,FYOF5M*O!&AQ*1O5#[3O$OW3H:DUFD/`YX&M
MD?1VHFSCFZ$SP<:ZB0HH7ROP/9ZE!<*QU7+;K;H#!W(#6#S(M-5,4A&8#4QZ
M*>[5U62GMS_8*-36(1Y45K[.(=5WB#0.3-O"#-4W2G?T$&6G1-LC3JY.V5FV
MIQ`7J2/_-FB5W0RT#O3[RF+YIXK?/!D&ZPV@J6^E^KM+R*:C8K.-!^8+S*:Z
M"68->&1AIH</EDKKPF4U?9=0[X&9)51U\.4.?FHK26D4*L!8U?%5S7RU#8TA
M$OMN;#JWT-PC,7<(=5:BJ"3)>==D-=SQS:[:=DP11)#%^G#E-`+>!Z?P<WLO
MD92W^<9F--3)+DGF./`KJ:$;'1"X<G6WV-`C,?4(-&TDO9&D5A-Y-5&4"^3%
M?'FA4'Y**#\A2,\5IN6)('Y/KY,I&Z2J9K&J"2X,`@<>AHIV@04&JQ4+28R-
M?%,#SUA+M,R5I.=^^4E;4P^=]-&_ON.]2G%"K+$AN[!``P(?`RV0>32V_<*,
M,>#)Q.@1974A:5$V"X![IUI)BHU`GZ2W\N16OK)!J*SEJ^MQI1YL/L3I^FJ>
MJ9('WP9SQP1<:YRD#Q!E7[RE2RP_N4:S^T<O#HTO,F?ZGX.64W>P/1!SZKVW
M?[U(G'HX#@9"W8(K6=H.8`5\_6D(_PG<*=Y7/7KDE/:KTAL>>Z*K>Y#M?A/T
MHB*%+;_,1[P^MC7!U"7Z^W\&UNUDT82R$<@P$#^QTL93U`L,6*$CS(:P`CSF
MZ21U]RIY_I=_UM0ZP')Z'Q^T8DVW1.$!_B\SM$IT+4)E8=K]17M*D5V/3=%_
MO!-:;RDB&\O`L,LR^X7&+C2J*M;4F->5F`<DQGZ)KE<,X8/")4UODZ79X],=
M2?)6<7*].+5.G-8HE+<0N9VD.TB:`_`FT'6@M=';9+HZL:(P45]TSP\G=A=A
MH0?>0B!$%Z=PB2GDG9_#O<X^_W@+23DDM'3R+&/0F7%;AXFR5JS%4CM<!P=*
MHVT3*)OYZ35QVH9KLJU7F6NNR:Z^94?-ACMK-M]=O>7.BDUWE&S<47:3I>R6
MC-H;,^NO-M8EJJMEJMH$@VUU9B?P<ZP6T;LEIBX`O\C0A5D.8P^&P.EEF5\I
M.%5'+\[0/[^Z<+VJ1)+6BC).\!=&]/4\O8.'-)X%?:E.GFF(*%T0)O.`#V@;
MB:)6I+5">)5H;+_*XKHFTW6UQ;;:4!.O+H!86Z+M$JH&^<HN8(SL`EQ@D(FQ
MAY=QFA@@BFD3&^Q)QO(DY?L/_KB[;8A^N/I@6<RPI`\*7Z;DC"Q_`-_X\2>3
M\Y&+0?KL.V<EP/JTU3C?#4YA1K<0;6P?2>\CBFZAH4V<`3"N$YAL:_3M&RW5
M)RMQ.=[KPSQKF&D;+\WZ69G,=)"5:=I[:.I##I1XJ4IDYL8D2X=0U<I3M$HQ
M[FA&;J:%R3BXQC3*WU1RO?F]-T[,+2YOD!@,K=P,(1(5V8+5.LA`*P)WH$6]
M`>:CT#RZH=.DAG:QKA50E'QWWLEF7)#UG*;?^+'[6DTI26X4F`<A;H*9*#(/
MQ66/"X&:XN@X9?H>D=PE36V-3ZM;HRB_P9B?O+U(<V]UQF>;MS_HW/HYI_DS
M;=K[6K?L:KXAJWZ5H5&J;@1C)5*WR#2-2;JJJS0YJ;L*?OM&>)*I6T)>IH\"
M,^N]`$%@P$<KFFC&0XT0F),M#KAE@:D/#92\/#[3)M*A>$.D:H.@5:8\<6U&
MCNF+]0_]3_\+>^E?#]&W\NFA2II32T_4TMQ*>K2,OE]`W\RAOWO#__5?]!D?
MJ+C.<ERF/"525L89._BJ#J+HY&GZ^-I^"!_XRDZ1OC]^QT626GECQOZ]^73*
M2U_XV\5KY(62%#M\C.C[4+FAPUDC!!X(,(;A4`VLVGE>`,Q9D9=HR;]N1X'R
M\\UW?;?_*[^<?.3IF<=^._^=W\U]\^D+7_KO;@BOMC_<>).I_&J=-4G=)E6Y
MP'3@B$!`IW,#NQ9#G(XTNR7!5!^G.+[K$5=)"X;;'W($EK)&7#8KS`1"F/<)
MAQ9#`+`0YF0CH5CY:S@\-XL)F9Q&>O/V_4G9540#X0#$Q8-P"WQ-#\2AV#2=
MV+<:AR"Y;K6Z[FKUR8?_V]UY!MG:)3\N;$=BLX#A*[KI(@#L5WNGUMYYDJ2^
MNV9[/?`QHNJ4XA+#$`8["A>6CUD&(=XG*0W79MFV?[6EP1,5!;%]Z@)("T-1
M_>DB(X<7*-U?2V_;=C@^K3I!Z<&^@MD-;!.B)&!<P$BU;1)YL>J>XOU%N$IB
M':3F3Y?%IY8!#X0@0IAEQ[HV(%WF$8B[>:;..(M3IK8FI%BOVE*18LK_]A-M
MKQ\>*FJYX+E`N\Y03R\=&*##([1WB+:XZ=X\^I6?]=YD*1*EE*[6MR>I6@2W
M'$[.//KGUR;.GH]I6?Q+,L)PP(<;21THF%ZK+!$I!GC*(:+N%:GM(ET34@4(
M@I1MZVZ_*%6YX^5%MVU_[=EW/!5N.CB-E70S?LP?+C)YX)*:QQN@Y[W8L6,^
MVCQ,GWG3<V/V;JGJ!$\!%@!Z=8QH1H`D`_.$;A'HG/R,'O!KJU0'7GS'=S%,
M__K>U#I-'O`HYJ1@RG<(]&W08V*M$_X$<Y*W]5R_\X)8>>CZ[%<^]Z,3.76A
MMD':>X:.7*00O'#M]$4Z=I&.3]"Q"5I1Z__%<ZXMVW/)QF-Q&=TPH,":A,8.
M@;$=*P5@9+5N,".K#)7RNTHKVS["T@:B,M%(M`O#?EQZ1UE0)#B/FI%P<*72
M.,+,V>`$??1_VQ.-1S"G"A=O/HLU")I!3-PA5KDJ17RS6MF2M/GD]B\V':G!
MS3<XL80OIE&-Q/;*XQ*N@+&:,7K_DVUBS9L0Q@HT#4)=EPC8CF*0;QQ#SZ5V
M8;I>VTY2FT4JYRW;&U\^N##!!,ESB]ZHH,[OX_R#EYWK+*7[ZNAMVP\FI5:O
MEG?'*SJE6E:2AGG.'J!D(IU3*B_6WE5ZH`A+=&J[J?;^"DEJ-7@NB'\%6UN(
ML9Z!=A#EP?I6D1$H8EG<QOPO/79^SQ':/8Q^@O64S\O$8=R]15AR8RI`FWOI
MGA*J^E3#:DVA8/W!3=EY3_UA9/!T;'6127+"84XM'!V%=XZ?7Z6H$<K'><K3
M`E6W3&V3@MN%``%EG%U2<,<;K3>8RQ]_P6H;#DXS90)*R`+<'L'^Z`(HQ,I!
M7+M<P%P]]$OH$J4-`_1+OVA*,N0@:#6GB?XL%LIINOCZ#K&^#7-ZY@Z>OB$Q
M_?AS;X9A5OUQW_@J32[X.TR#&#WP,9$.H@`'X!8B9;YV,-%P29#:ND;_YL_^
M9J_K"J`>;A%!@@OL(6P![CW39T9"X4B`MG>&G_S+Z1MWE(/+(XIVH:6+;W`(
M=3;L<`@PM=U@[A*T-<F[2DIL'P':X#)H5UK:"(1;H05<WP^S/@U'.)6[SX\K
M)@=+%F\P_SU.?QRI.]AVTS!80IX6[J(=R9+.Q@=WIL<K`1X5M_G`-Y\9ZYBD
MT`E#\_1""!>`9KG]87VH[)EC(KC9``7*`8/YPE&:\JD"B?(@$(]XF(-:#U'"
M?$3]-M&U\2$:PC4@.TFS"5,+/OU82XV3*:P"W.Y'EX(STYQ@BMLA$4ZZK]Y_
MZXY]X,H3Y8-8J/ZOH$TOT=Q9=J@$05O21A5WED*LAV7O)@\OPXEH`=""CP:R
MK6D@ZN(X=:[VWOK]I^B%.5R[\D>BO;@8]D=BFAI?>!QND9-(#0?I<^]/W+S]
MGZ+-3__@>5?/!1H5\&$G0P^'H_7O0>P->/.W_4-)RBJ!XC3FN#1=4HU-HL-4
M&\P:OJD/HDBROC%U5]/)1IR5G*,)<O2(L;L8I8]6Q_C]4?7^/"N<^V<NO6E;
MD1""(\T0,9Q!:ZES@^L!,HFC!F?1U,>G'O_=Z^'Q$'UQ[UBB,I<OOPRT8ET4
MM`)MKTQ]FK>I_)[O-]G/XYTN,-`N^>X(9Y>X^@A.%!1&BEADIYHO`6)K@?9+
MLWL`O1!N@PWG0`M!O4Q5N6%;?E[]1X,VO`S:8%0NSO85C[#:"]P/&\7VP2"F
M>@&Q/>?H8\_8!9O^E&0I$1JM!`@M>@HW\'.L"M<W\0Q-6!1@M`.!7&6RW[K=
M]NWG0[NKZ#ME=$_%PDFK_V#YQ2,ELT>*%X\5AH\4TB.%D</%X8,E_O=+Z/X*
M^HM_1(P/MJ[1%JW2624`SO1V*01W.@_/R#+J1H?0U`YA.$_3QDLMO\F8^\S?
MSYSU4U8$A_MU^2]-<9PGR``$]&!?P]PM._=(TQOB%",R)8#6M0Q:XZ!(VR%-
M+U/M*CE2AF(#B"Z3MQ>*MM1@/;NI%ZTKEJTQYVARXS8CJI/K+$=_OY<.3^/4
MFUM`S9#?MU1S.1&A0^"+_+3?3\_X6`G2N0AU3]/OOE#\^1_MRV_U<;YFP3L3
MW2DW-,LIN&"`IKWHY9][U9VH+!,HAQCA=,NTK>`Q,:N/6TUZI%I/4KI=?Y^]
M;80MA0?85DZL]H$;ON6EP@@K/N"J($+!R44$^<DFJOULLS"]D:_NXQE&D'?I
M.L`4`&AQ8<@`K+(I+B7GMZ\A:'__[ID$Q0E>NIVC!S'0PO4X&&B[R::66[:U
M_.T$>C3<,,T;]'J7=V!?QFW4J0?F9Q>`IMI&:>:W.HFRA@`YS_+P]#:^I@EL
M$=A\HNL!'RU65=R:=3*W^J,"L>#27EC+=8K<?A<(6G`Q$.DO4MP3"[]A,D)?
MR:')NPZMTA^.-U9++`ZBL;,LMYUGL/*,]="(L1&3;R8[]O-M$*4.7;-SZ/I=
M;3?LJEA_3^FFNPO7[SBU86O)IJSJ39D-&S*MT-9G-]RVM79]=FWZSE;=W3TW
M&^P)FYM6*;LDZ3TDV9.4<8:HW`!:GMF)Y08&F]C2+K9`$&V5;BG.^GQ=F0M[
MS,<)/[T+G'X@PD0OP$GV-4[?=/L>D;Q)HCPM70:M?25H%3M+<BKI^1#=7S*U
M,2M/M*4.2QN,PY@4-?817-#OA$@3/(M8F[OIKJ.Y+4Q?&F8KO\%870G2_[D0
M@O0<FRXHX/(S0`):'*/!AMZ%H1E<J?5'.QFKAB?FSXS[0IRB#"SP=(@^^9(M
M7E7"4_5"D`(XD6A;(?["50Q#'P2&8F7KJO06\WVV_@MT/H13AC.MN)D`LKO@
MDA3<3V/7QBHT)V?"\.5E=KKC89<XK5JD[L+%7,S(M6-PJF]%T!H]$`K%IYSX
MW6OT+%C:/><2E2?Y<L>'@U;7(96W&!]RY3O9;GXAKJJ4AA:7JM2"D>7Z1UR8
M7?3.`XH<X_3V[W4CM]2R#)@*8N1FD;$=5QD,?9C34%<":(]_%&BCPOCP9;)N
MK@P$;>P":GTBT0)8Z/R6$7K?#[MX6]ZZ9FL-22\5@CG5M@(G0<0:&AEBZV,9
M/!<.M_&<9.L,T?:2]"9<5%*6DHTGQ,H:E"0IG''IW5)YKT0!S2-2=4B5;8*;
MJM:FVA,WM\DV=5RM'U^E/\.7]XKU$(]T,-"R?+BFB>BL`I8VCTMO7ZLJ>OK5
MD6$O,,0`/H4D'(R69[%BO"FTM+,W[MK#5S2)5$N@;?T`:-.W%9^LH6<#].V3
MY]9;\B3)31!0$^,(4?7Q@4-J7$3KDF3V\S4-\?I3F@=/%+8CPF,R_:@Z-@+3
M)0AL<@&W3\#>"R"+BTGWY\(QV6ILH2<4\0?H]"Q=G,2'HU!'#W5TT=/3]*F7
MP3\60A#*RC#;)7H(Q"!L'""Z?KZIDR=O%&^L,-Q5UW\6F4F(PV34(Z.(FM7Q
M1;?*B3+G()9N@2D&1UG>2K=]H4625BY6NX2&;D2IWH&@U8']@6[IX:M;$U/R
MGG\-;_`/>R\FJ?(%"B<3R'&!&((6/PSO=<Y$5?W6+[?6#[)=UY`=,9484+5H
M"5(@$GL81ZSD+0`?`DN[XSMP]FH"'D39P-,UB_3-8I.3@78@"MJMIW)J/@*T
M4>7\,FBC7`3K-WTHW$#04L[,GIFGS^ZG:S**^?)3B1E-)*4*V#O<!6X4HP?0
M`C&`>*&)+8ZX$;$F;J&Y!WM#URC,:D(U%$0Q9IM0;1>JW!!E"%2]6$2`9*8#
MR$RBVK-&W1.?[HE3]JZQC">91_%7&C<,%I8_X#)3*R[HJ*T\K5VB[XI3C8J3
MZTT/%1VH!B[+)._8:8S>A7"V3R.G7;Q^UWM$U0"!`Q97?AAH4[,+\^KHN)^^
M?GQ\O:5`FF)=`JW0`E/&`4V<T4^4U@1M4<;#Q8W#W,YX7+E?)/JX"'\T!%NV
MO;'I`Q9H?GXV$%ID-;&HJ0PSD=JER.(4BQ:/-41^_FS3F^^-])^COWEM0*;*
MQYEBP(VD`+0"#K2&?M%6#U]=+]Q88KZ_H6.(I5W@N_SSC.8%V):\$T'J]:&#
M9'6)J%\/1A8F*);5(FC+K#3S<]6RE$*IVBX&.V!$[0T&[W`*-;SOXZL=B2D%
M`-IS0?J'/1,`6KZ\G>GG>S\`6K#_XBT%MS_<Y&*2PNG`S,+B^;!OGA4#`6X7
MN=WHN=V266"*@9HW1&VG:?:C-J(MP=%4UTLS[%'0`M_0]X,!YT";6_M1H(T6
M/D9B+"B:*P@QT,*M!WQ<3NKB'+6/TKL>[R<;<E9O=XGT+3R5+<[LQA)%%5!9
M&QA;YKL=&+"`(S,,XX88P.%U-E%FF]`,%K(20V^+5:!NDNA<8IU'K.T1ZOJ$
MNAZ!`2@K."F6=E#:B1+NQ0%A'1(/C0UC]BRV.8RV!3]C!$+KA";1]4.(+4KK
M$*7L^>G+/>>Y1XWX6>T47'P(Y18SF/**7+?K(-%@"3F*9#X,M"E9!04-"-I7
MCIP&T,:EV9CR882H>R29`[ATHK!*P.2F.>)4Y5E?K:KJB9S#ZH9+T#&^N4N,
M6@7#\[@14W#)S*PH`4>B%66PTU[O/%<$-N/#.34.T5\W_=(3S:9=>UY^_>+Y
M!?K,*T,R=1[+)=H!M%)#*_(]Z%*P=1G@3VLDZ54[O]1NZXVI+]"\A%G"]P*3
MW<T$,6<0P%D;8@(@9!\H?IP'2]M"=WRQ7I9Z0J9I$G,+NP!:@TL$%$CI1F.N
MM"=NR7_^%11&OOCNQ56*O)6@!:\*1`*@RT#KD&PY=<_7F]SG47CLXR3SX4!L
M*_4/>'#<CR(2N@3&US-!=WX70%N$@%'72RRM0ET3KM<#&</J?J=(77'+ME,Y
M]<R7?01HH\^FB<1`&V:@#7.I`SH[CW\[&Z$O[!Z7&D_`B7AZ>RS)S!J@*ZTA
M:0=XT@Z(!_GF8:(?(:G]`O,Y,/52O4VJM\;IF^/TC?&ZYGB=-5YKC]>TQVO<
MT%"Q#)Y7WR;1VX2F9A1@9-012S7)K"69U<122<Q5Q%++S[+A^@+@W^26FGN%
MFDZ^PBU2#9#4TW':$:FB=-,=.8=J6/I@GMOG$Z74X#:G@O3]:GKSG7#95>!M
M11K7AP9BRIUEQRO0(;Z;?W%35F&B`B8.6*%!F$VX9`]L!UBEH@_\PFI#Z\W9
MQW):_).(QWE_Y!R7NO(MC(?]4]'(?:D^ARL2#,]0K'P?9RS@$H#8Q\JCN#CQ
MJ(W>_7W;U;KW];<7[CU*@:D"5"00LT,LKX%X%@@D6VVT]&+=7)85%U)ORS,_
M9*]VX;BP.D16'(AU%_#]8S2ZV23+9H9#X1!FK*/L.D*!NN_Z:N,J=8%$`WZ9
MTT@`0>T0:'M1/:+K%VD<LHTYS[V">9X7=I];HRK@I;<QQXTR41CZ6';(!:\R
M!EK'*)XOQ/&D$-OC)Q2.QDJQ![J%HK1V#D#K.D=W?=].U`5`\_C&%AYX89T5
M00N(U?7Q="X`[<U;3QZK_3^!=GDI#..O>3#M8$UF?8C8HB9ZQ[?*A,827,N#
MB]?ALHA(C0W71U*M`E,WKNMI/?';+D@SSA/EJ%`WPE>U"]16H<HJ5#>)559L
M2AN$$F*E0\B:0-7*5V/P2+0-1-^`VB13/8HQF$*59-:0K'K4:9@1L2SHZ\"5
M"W47Q!$2S0#05)E^5"BWKM+F?_?YTQZV&2^KU;N(A:<L+CI006_<<8+H2H%7
MB#3M'PK:M&V%Q\H1M`?+9VXUY\3+FW#Q2]?%#+L=PEM4)"H&!,H!F&Y7FTX=
MJ$.+AJB;O^A#+A=@CR.9"847(DNZ9;0RX:!WVC]WEF'U4B0PY5V8"[(2W=D@
M[3I'?_5*[Z=^TG)-1H'@MB/R[)I].<C!_GEL7J8YCLY+;\<<ILH*3HU8NDBF
M$_51V8TDI5SYJ=9#E6P/<S_US<92OF&8-1>P@CCHB_C#W$(YIX">\J'``PSN
M[CR:?E=!@J90I&E`40?8.CV+JC3]`LT@4;C%&OOJE!._?YU>#-,7=Y]=K3PE
MT70P(6(4M(!5'EI:-X)V<_X]7[?&0,L(]/+^/-%UR16@Q1T5P&MWG*-W?L].
M5$N@;4;0&CL0M+CNYA)HRF[<EOO1H.5R+32RDAM@L.E#=P/#,(\^Y9R/_O?O
M>U=K=_.,U:B=0-`"5CM%:FSP1I8QA`$F,'9P)4H/3^$A*2Z2VL[#_)X[UCR7
M-1.G.6PGEC9BL3,E*L!IE)C/$<LH)O-1_.E"/2U\$DN_NW!G&/#:2I=`W<$(
MAAO3F*8A@;*#;"[;?$?EZR>CBQ>!X$7<<)15L!XLIS=N.TDT)0![B#XNR]-&
M05N2NC4OIPI#X`);Z";CP3AY'0]5TTZAT8;*![!(P##50WS5,!`,&/&'?^6N
MZN8>#(%/(IF!J!^"9ER7P5#(AS%]Q!?;Q&!)#A$)87KJ_"7:UDO_]M[TY[Y7
MLW['_CCE`;AXP:8:Y3;[P3Q,5K]=L)BH/PI!'P34(D,'"D[4K:B)19U5'=EJ
M!;^VQE#Q^.\'G:,X.GY&`2+!Y4Q7=%DP2">\RY7"<+7.,_3'+XZMU1R.TY0+
M</,?W$<%&9W.#8@5:(8PP:BW7:O*^^/;]&($;/[I^-2C\;H/!RV\2K84W/-U
M&X`V)B,,K-B9,`;:\$K0SJT`;1&,"-_0"@8?9JC0"!:O'ZE[#+1'ZSX*M%YN
M0[!E;A"AL?UFV;9"0=15YC92RQ<JA?)#+,Y"T/*U8&,[(:X1L75;E&TK4)PI
M,+N!ZB08[-=8G.LL+MS0``(Q$TL<+37<N[X+A9UF-],.Q1K\7'F&I[[$UU[`
MPG,-YGQXVBZB\?`T/1+3B-0\QA;*.X#N"MC-DO1&8`LH%T]O!9+PT!.#T"'H
M&L/SD0B"=BY(CY33]3L+A+H:3*$CIW5SLO^5*V+IV_-.U:%;K>NEF[8>BU=6
MBXQ.8FH7FSG0VIE>:U2@'1:J.B2*\NLL1W[]QK3S_/*#&R9BA9#<\O%4["D/
M0/;.+N!2YN`9VFBC;^V?^]GO!C[W'7O:'862Y-VK=#EDRTF9KFNUKDM]A_M@
M`=JW]ROGK\T^0M++(5Z0&7L$:6UB;0>JH3):4%^]%>*R3L#YECMRG_['2$,7
M'9VD9Z;HQ`+.'0R(@"K/XVZ`<SYZSD_/1NCI(!WVX7+8S_XRM'[;<7'*<:FV
MD2TEV%ACOEX-(=@`S$V9L>DV2_'+>S"H^\.>T]+-^V2:-O2AADX4Q^H=@%N"
MH.T$BBC>4G3WU^T0[,S06)E;Z/]C:9$>@$5TGP70MA%E,=$B/>9I6S&6AUA;
M%P4M7U-VPW8&V@_%;'0/BI6(Q1D1QKT%`G.+"("N"_1KO^Q=:\B3Z>I8J`57
MSK1&:C<'6C!WB%AUNS"S0Y;M$&F*)?*<I+2#P@T'>,HFP!AF;R`87VKJ3I0?
M:]JQH@$;_"W[C**'W.H1;>R1)G=)4ITRN2-!ZY1IG!`(\.40M0V(]2,"5%QW
M8OA@9')K>55<I@>K=_6]8HWMUMLK_WH$F"674`_`K)OUTZ,5=//M>3!,/+6'
MI;P\EX.V32HO5-R>=ZH>@==ZFF8\5!FG+`4;R[<X`;1BX/`Z#"UYIA'4L,%\
M4=5)TO/D]]8__$3?BWM\)YHI6-TR#RUWX^8#O6<I!":.\[3N-#WAHF^6T9<.
M^Q]_;O2K/^J]_<&6E,RRU6FG!)M.\N7E,F-#`G"AU)HXXTB<JE.^J^5@,<Z"
M(K=7_D`!2<D3:YT)AB%1:J>,27U0OVJJ(QF.^,PS$J63OWG?K=L.W/?M^J_\
MK/U7?Y__[9OS?SQX\<^'S_UYW]2?=T^__-;B7W>'_[B?_GI/X+]?'GWL^:[/
M_+#Y.M,^<LN^-;C5:CLKOD,A-V=LP3C`.`(=$FO*Y;LJWSZ.H'UI_VA"V@&I
MVLZV8UT)VG;.\`J3B^YXQ-%R.NK@*(T]^#*VB5XDAEBV]#$?!>TX@-9)%$#8
M'`*=DZ?%;8I1[L6!%A_#47K#]N,?#=IHB'<Y:'VA`-C7H!>]'G+"C;>?$J26
MRF`NX!1SH))Y";2J'KQ92Z]H*WCS!J+(E>D.;]R5J[[[B&+7D?4[BF_:67/3
MCKJ;=C3<M*/Q1F@[&V[<67?CSIH;;Z^Z:6<5^VW#3=N;;]K>>NO6EDU9]6E;
MZU*W5FS**MZTHV33KJKK+.7B]&*QHI&DM9)T%VX"AO++-H):TT:!L4&6V4[D
M;4)]/Q@EDGSJLX\[[2-H\5C/A<'2'JT(;]J>(Y(W\=)ZI<H>!EHG`VW?$FC3
M=YS(K<&PR#U!'WEJ*!&Y!%!KNP3B('T[FRE#/',?A$(0E`$!DZEMO(VE<9M/
M;-Q6FO&%NJU?K]OZ2,NN1UKN_6KM_5\MO^.1\NW?JC+^5U7ZE\MNOB=_779>
M@C)/L.&D<'W9*E7;:G,WIK`TK<!2XC-<1&X5:H?(Y@;5/?4Y3*%A.QMZX!=P
M4Q"V.Q+T8[*TOGA]/XK<($K=AKD4@68\3CLJEI>)T@\DJ(]`6V7(OSJKX*8[
MC]QZ[^$-NTYLV%:P*:MT?5;5U>;2M9E%"9K]@N0W1"E[I&DG9,JF5>9!=%B8
MI'40LY5IN5%6RM-T('M//[7C*^UY]>@F_OK^T%K-48FVE2'\0T`K2"[9]0V'
M=0P]RR*7(EBY45Y,S<I`R^5/YL(A!.U=W^T@BG*(%`0Z7-P$4X"@U0[\WT`;
M_!?0<IL20P03A*&W#].O/VE?I3DN4=GQ3K',T"[4.L3J=JG*+8V!%A,@VYQ$
ME<\S'+W_Y[VO%M*\1EK40(MJ?45U"_A:&RBJ"176A@KK`H5UOL*ZQ<+ZA:*Z
M1?AY<34MKJ*EE>RUV5_<,IW7-'&\;B*G<?YP(_U''OWE6^$;=I2*564DM1;C
MW,Q>5O'D(%EMDJQFH;X>^A!K3G7=9$O9IEUES[\]<=[+[:&$BH0CE7/KL]X7
M)[<(TTY+%0/_`EJ'5)Z?OB,'``/#-+1(7SI$UUDJB;J"&*T0*6,MK788MR2%
M43,!\6X6FEN3+,,)BOXD1<<:9;,XY019?Y"LS^/?5KAJ?5[2^AS1QL-DRV&B
M.$9T)XFAG)B:X\P><$F"]%[P%RC@S.XF6]M)MEV:B;D7@6Z`;*[:^35'31>.
M?J^//K-O/AYBWN36!/5X7,IPHFX8Y=G9=MY6.^KW4L>$\O%$0T>2I3'!V"@S
MM1!%$^HB#(7$F"_0EHM5#5)YBR2M5:;ND.G;DXQ6+.-5UEQE="<93Y/D/JPQ
M-`P2LY.!EM7F:-MP95P'QN'$-WXY";B"WOC3WMZK=4<%JD9N9YY_!2T_I6CG
M?]F;SN"'%[A8;`E(T3TEH]N'1J+/Q9J)@O8[;A3#:UP?#=JCA^L_`K3A)<GT
M,C=@C^8(3+,G>;V2,WY#YIMQFE,R^,YT1"SX99X!=YX7:B`.ZD0M/5`L>8,8
M`@1]SOI/Y_V]@*U$A^FE>70-2]\?W3XPLMPNV[B4J[6/1'>=FHLQPV$_K1FB
M^H?RUV:<Y"M*<?/Y['Y6<]I!LKI$IE:25AF7C2)#HNSDJ]J3M)6[OMK8.8+%
MZ2S'38]53FVPO!N?XDA47I0INR3Z-BR[,X*A`VH]"/Q0(B])O_UD;BWV*1C;
MDS:Z8=<I@>H4WU#/4S<#$<+9BFOT^(A)8FX69+C$^B%^^H`HK5>B[)"HFU=;
MVM9D]DD5'5<I7.O4SM7Z=IF1/5W"P(K%U,#?/`+3:;'Y+-'THYC<!(B%J,K.
M*G=PX$C:J2_\S-EY$?L<EYYKZ<U;<X7))8FJ+FEJKTPW0I3M9'LOV%NQJ5^J
MF13)STMUO1*X)"5\OTN2,2(P]V/!(.Z9UB[0=HO5_6+U(#!50#Y`(B$#HN-6
MGL(M-8P3]1FB'4=!*;A.7+MDU5LXH"V)^NHDY<%?OS)W(8R7\=LW>]>HCY/D
M>L9INS!QA`5B=F[/$_"Y:&D?<5E/1RUM:.E)\5'<!F//^P[$MI*:"8:IYPR]
M]]L>W`E!U8D21V#LJ*GK1@TJ&`<]X*KLNAW'#S5\!&C]2WL`A]@(S[,'QH4Y
M>9+M#/W,3RI(ZM]EEA*4P:CJL;HGHY18JE@A/*N2QL5KB"X;$K,J1>FO/_)K
M9\\$9K<7?2L4YI'_0UO:'#*TM'T-;K`VR^;G"[O/W9"Q5ZPXD6!!538^.$_7
MBTM^FDZIRL4>]N0F6@@E^A(4KFL41;_^PYEYM@/&=("6M@0W&M^^.MV3E'X6
MJTZ,E<12P1ZOXR$FW(I<D-Z\/NMXL9V>#2.M'0O3'[S8(DEYZ^JL9K&V46)T
ML-V37"@FP1W&7/A(*4,OIB[QI!!Z6UD5H14"82`;,E,'S*QH78G%B5OO8OEA
M%\L'=F#:)+.'9'M(!BKG29HG;MM9HJA(,K[_U)L#0]YHI#\P07_ZO/,:Y=NB
MS3D)J-GK(^I!DGD>%XQ4W0+YH%`Q)-'T2;1=$`[SE9UB;1_N.J)#/8!(Z^%2
M@D*4IS*816L,72AM`@-K&"7I7;S,,?'V41P[=:LDPQV?U94(9C;IY:\^UES2
M@NJX44I_LV=RM::2G]:%<3'80+@OS//8288-=\`V-<E2:C[]C>&V442+CUOS
MBJS('K!T`?<40@8&L+<3,"B#$_3>1]Q8P:T9PLT9-$Z2!:$TA(3CQ'@.@B">
MNC+)?"BGE55^?V@<%GV:BQ\W],#T<X`3]9WVTY<.>N6?*9!I3V#IEI[=?D8C
MR:K%;5V!25K`4@W@6JW)(S4W"^6'E/?GO)L7F.4V@<?+_I@[B(57[(S,,AAL
M$QL<1VL?_?)/'4G*P_'Z>C'X*7T/R1P#E,)@@;L78)UI.R8?#'U23<\Z5?W=
M7VFL<S*98)@>KIK:F+T[(;DU+O6T3&T7FVJ)I8Z86]B5GR.:"Q">;]E6"'QF
M`I_DN'")TOR6N4\_VL2_=:],6XEBI-0JDEI'E!"PH#@02V*Q*G8`BYL,+!>A
M;\6"4V@Z!X-'!TI!M$SIAP`&ZMB!#?X)U%39B`T@;>Z*VWX1"`_9M%?UX/'W
M:V8F8QM\+49H;LG4?5\[F93ZID!>'+]]D&P]BTD2?2\B4^M!$1I$N&I,XPCU
M'J2CV)RQV+8=EYXU#@*N'!!K6BH>[\/28,LH[FAMP#)PH;%+C#OR0;Q0*]Z2
MJ[,<?O/-L;->-!3CE#ZS^V*2JERJ[!.H3Z,9!,N,^4DGSKA,<%4MPEO*[OE"
MM[T?\WY,\W&)*8ECQB>ZCQ9;[&`P7J3G9L)^US"]_VO.^,VU\9I^:=8@?QN0
M)2?;I1`FT9#(T+4ZLWG=UF-'FC\"M,O9B2#;]CH$UMP;IE,AVMA-=SW<$)=R
M;*T)2!1P@W&^]@)/,X`I.WS*QC#1CK$&K-X=;V@0;-G]V&\&NB<0]R$6S;'5
MPX]3!+PD-4.D<P]EGN=44A#)_NU@^#K=`>&6'*FFB2A:L#I#X6`%"*W$W,!V
MS&A!;3\$5IJ*F[/W/_U*UQFVK/]VS=3Z>]\3:1KC].>$\GXA6"VL;>]%7J>=
MXLDG1)O;]7?6GZS@MMWT<2<^6$CE._+%*<>!D\29FE=GN^/,;J)L(W(G#VR.
MO!LAI&(/'-$/\DU#`O,@JS9"80_2,\"MH8-GZL150J"","*F=I[9R3/#:SOF
M);)<<=ENK,[8<G*=\;V?OMPS,,<VIF.2";!9YR[1/<?FLQ_,YV]XBZ3DBBPM
M@BPGEE&8F_E9#KQ9"$4QG]/`-@RQ?DB#WM"T8UH`UT;[T%S#!:O[>)H^*5N2
M)G+;J@P/<!M^6H4HO?36S,*G?]?;QB;[%`V/1.C3;_?$IQV4I=G%2I80XY[J
MHN=JY[N`C<>M+__T5]S.(>RQ(/;?)--^K`0MMY>DEQO6$+T$..P]3[_XO<ZK
ME)52)2L,P91(%<FVXMX("IO4T+HNJ_J:[/WOUWT$:)<Y,XH:`DQN!Q'WN3GZ
MSWV16_5'Q;>=O-X\'*<<%Z1/RC1S8L4HQ#)BQ;!(.2Q4C@I5`^"&9&JK(.7X
MQAVY^TJP[M@;YM+IG%_X.-O:+-&AJ()[@BVC(VL!AES721_\GNL:;>YJ37F"
MOFE5MA/7JI!G.O#!9)GUZ+#`<V'95WVB\KW,+QX]WAH\3>F;M715]CM$62O0
MCDH4XS+U&0Q\,"$PPC><DZK&DI);C#O+3^1'V$ZM05\H")@9GZ!O'Z6I=Y4D
MZ?,$:<>EJF(P\D)U@UC;EI39'V<9DEE.2\UC8N.H0#>$<UF)E7&84M8B3P.V
M#W,9&EH_%=OE0VDE*JM(WQIG<4J`42OJR(939,/!6[)ROODK5XV'4U?2V<4Y
M&`C<WSA$QR;IV\<".[]2*DU[E22_(3:>(HI\HJG&+$T&V\8<-U!MPF:H1_1^
MH.FL$IU;INV&!@Y(I'0+Y"Z!PBE4.JZR>&3*!HF\+$%1+-Q\2+QYO_S>QF\]
M.=+5A^==Q*6U!>"T?SD\?*WZP#JE=96Z*T'=+]-UX8;8VD&)=AA:DJ9S]::B
MSS]B[S[#I6O`7$V@$CNVJ>;R[F0<:$-TUC\[X</=%Q]XU+TZM31.814!)S%6
M`>T4[["ASU+8XK6V1$W)C9F'3C1_.*?E=NAG%6`H'@:O!%1PVD^K6^BGOU9Z
M=<J>U<D%:Q2.M;IA<<I07-I04DK'ZE1'8IHC/MT1)V^-4S3%*RN35*?$F_[Y
MZ#-=R&8C^(A>]M63_\Y>3!'NHCB5_3GH!/:8>Y0GG9FF[QRGZITYDEO?2$P[
M0C;LAP`*=UI3]V`B#I/D;&U1W1>OZ%R=5K$N;?\/GQL<\-']352J/LQ7MO'2
MAZ3I0PG*;K'&SL>5]V:)WI:HM*W9DI>FWIV?MQC52H7]N``:P!QO3AW][O/G
M-^_*B9._*9._)U$<$Z:=Y*45BE1U(F6S0&D3*.P"15NTR5W(,S4#T*0:)"IB
M59=$Z89@+5'G3M`ZXS0.F<(J530"8!*UUJL-E5D/5/WJCT/5#IR53!$6#`18
MRI-5Z?J"6!Q1U$Q_\OL._>?V7F5X8W56G1AB86`7B@:^VB;2.8!%XR/\M-''
ML0DT;0*U$_=?4K4#.`$5B<JF)%4SO"8H&^(5M:M4U3#KXU)R$E(/7B7?=[UN
M;_K.0P_^P/;:,=HQA"MY<.,+N&$LNLF7WNU=L^%5R8VGKDYSKDWWK%9T)$&3
M=R?)^Y/2!]>E.V77[[GWBT4`0A:%S6`0&?9>#EIN'UP?%VX'69'^\#A]\.NC
M2;?]O\ZN-2:J(PHW45O`11!L:FR:5A#195G`]*5-3!^F;?QA8OI(K-56T\;^
MT/YJ[`\;F]9:BI9E000%47=96%X+LJ)64$%,:]7ZJ!$?%%!67EL6EG5W[][=
M^YC.G+ES]THUK2838XQ<9LY\,W/FS#G?UZ%+OT*"AUF=3V1WQ+[ZQU3C53P[
M,_!G4UKG+3[>^I#"QHBB8,$*1N`)R1M&6[9WS$G?G)R2^XS^8.P+UF3C\=@%
MQV+G.Y/F.V:EV9/2[8GI]H2%MH2%!Q,R]B0:\I>\5U77#@47,BFF@Y,`Z'L?
MF?5.8MX[33+U@$`-L.\*Z&HW^GA#Q]R<7:FO6I+UQ2FO-2?HC^DR6F.R&J<M
MJIVZJ&Y:MC/6<`(OX3GZYO@Y^:^OL#=UHK(6-.O%<EW.D1A]>]S\7^(7'(XQ
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M=F'UK'E-R?/([">2=B@QS9F8=C0YS9&:;?U@??/5VQ2T7O(P*`4426&95G9S
M2O8.(`S;]5X(7;N%5JX^GY2*482M5S/-8)EBV!^38X_1'WIZT:F9Z<T)<RT9
MBZLK&T+A!X$V+"O>!VW$=*!:>.STH'G?I8**[M*:\9T6SPZ;+[\FE%<Y7F0=
M*[:ZBRI'"VUNL\UMJAXR5;O,]MX#+?U]$Y16FOH&$B2)!1^+7Y0N3[``R(')
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M]WQ7U(T!N6/?Q([]`9.5-U?QA=6A7;7!O8[`OB9?4Z=TZA*ZYD+N(-EG"/&^
MA+QTCR&^:(!R99_K&C2773:5#A0?Y(HL7&'E&)[W0ML(:1@#E=Z\DL$22[_;
MCS^"\4FGC(-(E`I:EIVI7%7\03&`CS#[X;MFJZNHUI/?X"IHZ=_><"//T9MK
M']CM\!=8ATNK7-:FGMXA]$`NKXBL:K:0TC!\"0@),JDW#).!C(<4XO%!7GED
M]T%\P2\S\G;6J+F](>7>%0X&H(Q7>%0J9R54K`GKP5^$0$`D?*W`D,U'D)\C
M&R]N^`#E186#6J'7ELD.2<0*X'7!X^&!6@%H]T&T]QX\\XTAS8B@E!6X]<"O
MEP-2>`(Q;2\:10Y"W0&-1V&7Y6\)W>71K3%T:0#]WH/.W"18PG[ID8NHZ1PZ
M=`X=O8Q.7D,=U]'97G1ED$A8]GI)WI&/L<?#G0M(:(/``(DD%I_V@SZ.HL*@
M;B:*@(A$(I(<9#;R$M7U8`T6-0;YO2`IAQB?0*,31#@5]W9<GDRJ3\T:8J&:
M<$24Z&0172G\56\P[`K)'II?21CF16(W'YK<)B3D\L`!A7],=`-H`U3=AA59
M1V0JX"5"(A8:N<?WX-^$<4NKD(8D$ANGS0W_,LK!B1_5>WT02A#2A/@C4=$*
MIN;)1!PB(9"H`%Y]LHVJ@A2J)D4THTF>)&OROT$KJZ_6$E.WX!3'6%9>*$C6
MD`@LN:*V!)XFR&MR64,LFB=%PQ*R4DN%!^+GR69"LDQ%%1R2FBS$,6MSK+B#
M6%YKD"`C;-?^Z=.@0JNV$-($%^G[,I7U8JN4&I\#`1H."J\E,7H"2A"B9W36
MPOTMPMJ_]4L$1>8IH&G:R6*95[SB>1*Y0%K>16]/I,9-T$B-0(OPQ'2X\2%U
MEU!2"VATBZ,25)JW,$V!,-WDJ/,CW]<]1=<&LL+^`SRR^G0;82#A-=%A\F&X
MG!&J=0%N1C*I8/,*D)$'8C=T8Z9[GJ`P93P6:&66,\SV6X'U*A+]K,I\(S/_
M5X#R3*W#KXI6\5%4(W5UDIQ!\H8@$])'/*(`>W)4\<.#?\?+JI<B>YF>'8>8
MJI'P$)D;=2'S#*AA@D!!C+[U^=C\^MAR4/1G*&)5BB>`KC(%2@?PC$;0?6U2
M#[1J-T"4/DGX!KHD"`IDU/Z,(1DNSA)(1"D#]P(/:T2,+A&,87QD#0@D<6P$
M3SH=*1A8$]T"T*J+[C[0TI@2VR)H!3$UD1*>E]B/"0_%SS^G(&3D#0IE;F1S
M=')E86T-"@T*96YD;V)J#0H-"C$T(#`@;V)J#0H\/`T*+T9I;'1E<B`O1FQA
M=&5$96-O9&4-"B],96YG=&@@,C@U-PT*/CX-"G-T<F5A;0T*>)S%7%MSVS86
M?M>,_@-F]B4[=5G<"(#[EM1NUVTVV<;NM#O;?8`IR&)+D2I)65%__9Y#$J#<
MU.XE!ATG#N50!,[M.]\Y!\JK[Y>+GY<+FBBFM2$4O\9KKA*MI)2$TR0U2FF2
M;Y<+3B1CB5`J8R2CE.B,D\8M%]^1:KE@!+^:6[Q-W+O-9"Q10M"LOWG=+_KX
M/?T#7UTO%Y]]86]R29@BU_"^?H?]$JR_8L0P01A+#;F&[65I(IA@DES_@E(Q
MHZ4FUX?EXL7%^TUQ4W0DRQ+V=W+]XW)Q`0__YD_O!"04#^T$=!%V\H)\S"J/
MR,LXR"`&:56B)*>IEU9(P0=IOSA_25[N=DU]YUKRLLSK*M9N4CEM1R1&"C,H
M_\4/G/-HBV9AT4]![I21Z[S7`%ZA_"!TWAROZO5'[H`]L`/.X1\I98/<.A%I
MAFXQR)VJ2')S,=D^FG]QH<(B-*$H5MZKN;]$Y5Y^0]ZYJ^NW[R(I5W`62[GL
M8;D%S^(K5PAQSW-YK]P7GT1;3YX:DXWK?3I>HC%%0LEY+)6:&?Q5F$E$@/]4
MI)IY0-0F'>'_LNH:6^?[TC;DM:O:2"E`9AHVDSV!Q/SQ#*!3[T,0EF#D`?_&
M:Q3XC3N0$@0E>=TT+N]:LJX;DMO.-A9?'8IN0W:-:V^.]:ZP$9.5,#Y9<:I-
ML$W*5#9L]9_?7KRY>//JXMV79^0*]O6+:TI;K2(Y):<F["D>B)X(CIDP6D;@
M=`9A(-GY17J'R[0(#M=?HQ7/7>ZV-ZZ!!'(&2@8MQPIXB.DY="M4^D2Z?0PB
M(0A"A,A$2`;I=X@0D$RD@VY[!G=&+JL\(3_0E+[YS]7%/\C+SU_#"W9&NHTC
MA[HI8X5,FDT.\+0D[]%%3S3#$@V<;]"+S*0'N18@SJ[`YXHJEH&4DO<@C"DC
M)P@3H_.[HP-L;=R]30P/>_<E[N6KY>*_Y'_P<K5<P",3="W\#D_5;'I9+A=7
M3[E[S28?AN3(8?L>@"$Y\S$Y$D#;6/K3,CUU<":,$=[!A92C@_N\1-I]<^N:
MXQ_2(SSZ5(]&TFAZ-)+%QP+,&2SUFE)29=[3.).>K]FJJO=5[E80];;K0__;
MY"HA7]3UJK?C>;._)2]7VZ(J6N`\75%7/69`28AH0>Q0%JY(`2S@$Z1_JZ+>
M=1!$=K4BN_H`5T]0/+&'^;W2$%*04T:G5)G0)CJ]5V;2;C0+*N2BWH0ZR62J
M/6I1PYE^POKI$?UJ]0SZU7H&_6I]HE^1<"-2X[,"Y=G()R_?OD[(]:9H204D
M.%ZPFFR$-9YH*9BWM*"2CCM!`GY&#ILBWY"#;2%-=4V]VF/T0L;:VNH(WWX$
M7KZUS4\.XK'>=VVQ<D-85T4'-UYUMG,M<;8I"PC-#N4ZPJLS@@+6AY.`KB8X
M0+(?RPA*3:(_,:(K!>!M,H_HBH673X[H:C*@`:,!\QH,"$MJP4>"$9%8H`.-
M51PXD$@%#9F9IL8,Z^\`OUWU8;DV^G=?X,'?MJK!\N`<+M]4=5G?'@',[RRD
MB2V\NW<&](RXL`X2$&-FAIT4DK)78S382>6)K9X-UA5_!OTJ/H-^E;@7"Y(+
M[9D/Q$4ZQN*NM!UX\M8#Z@8`]<:Y`?2J?5][UI6+&:]IJ(&T9L+WW;GL<U*/
M>INZR!VIUP/LU1">7>U;,"?QB[@2$-('^0]<TK:`H`5J]AOI`FKJ-(EE`7CG
M2&^-3"04?"H4>"):936MF26@6\I#+D_5"(#78%NOAI[*@FJ[`'VV+.M#2[8.
MM;QR97&'-):L]V5)&EO=]I;X>6_+HCN2NZ+%!R`8;H]!Z;&$8S)(-UO)K""%
MF=A5BN)BDHPG/-,(@(/=&,#A8+?*N150G[)8N[8[EJ[M:Y.=:]JZLF7,&)WH
MH09,X2%&S1BB$(1KUS@(LS;!B,,_EQ6ZA'L/^ROP7\YF2)<<T-O,S=(Y%"@F
M-DOG&9W,\&SI4JAGT*_0,^A7F$F_V(]%(?LI4K3ULM.P2MG4ES#4B),Y4M]"
M@/*+W!8X>#Z!64#E;=TX2(5;`.#.WI0.-F%7175+5D7;V3[JBNU8RL3#!YV=
M0)>B)G!NPT:>`>G&-5NW*J#N.DT:G6U_:B&O`_6P.%;9[O;8-3G4S4\]N+GW
MN2M+Y-M>H/'=9[%H*50,7IP/LK:,MJ@.B\8CW&R2#+,GA_P97([[.71KBQ5I
MN_WJ"!0!_*TK;FU70V'\M6N:([F"0FB+;?-_)>?)&?EW4T,N:L&0P`DB^I<.
M_H6/\QQ1<&/&LPEO=YMN8\MM7Z?![L#3<DB)4.X#>VF1J<`&K^H]%'R?VZ8N
MB\KV_N5O/"^03((<8_OO"JZWY.+HR&4%.NC`*Y.83-U+.!]1!+9QHE:E,Q;"
MEF=2^@DOHD^!)'%(WSU#7-6`0VT]U,_XT]9N8Y8(.@T-7*[3P&@Y'SM"-L_W
M#0)+3X<:-.D`AF!O@!38["44-G<]4/:L%DD)U`CKIM[.0$JDROKVX:Q)4VH=
M]!8-4B2$7S`.Q*:6_*3?0J>C+;W;^%HS5KV50MKTNWERZ'[H<$)JT+@\<GE`
MB?;5`4U2I62`0*V%G*JZ;Z](#MC60UK7%+;$>C<O]RM(_Q9<O7$N&@GF88\4
MX&0\A/-IM.5,6`X*W931T#F0+$M'8(!,!0BUKK&BC39K5G/*+?2D9HPXJD3H
MZL"O4>[]#B#.;C'G54-7^Y1^(4J>LBDHY8G-]X#R4+T1=",HV7+@7':H]0/=
MC(CP$Q-6E`I?V?`TS<:>Q6%3PR8WA4,FR^EGG!+(UC>NZX=L'78M!O\.HK53
M?HJ,[QP$F+LHDH(&K<7#=W`N_>Q%9\J>0;\IGT&_*9_T.T?1F0IQ&FJ,T4R'
M?"WNG5[L>Z4('N41`'3?`(BN^ECJB=8I*F!D`GEV1=P:LZ?]XV"0<AH.]&0L
M&_>-N\MK[&N69!@2QHU[!FE?TYG]DFD:5!'OT(26D[Z?+>YY^@SZY6H&_7(U
MZ7>.N.=:G,:/8%3S4.P!G1SL*3'N!P(02"1V`@IL-)=0[[6;^M`3R4UQN_DU
M$$`1V!7MV@X3A3[UUC@Y@&5'.A&W1Z!T(,A:9>'<@/+H$/`*V$&''3)_U.=(
M#O4>P*VO$*<Q2+&%>J7"PP+VUA95Q"&12N<?$JEIZB9Y/Q@:T%0;7_J_'&;=
MJ]/Y]^7;U^V@-S]]PQ[>R00.J:7%GM$6G6%+;#,<NUC##UW;D=NF/J#NL9W9
MNMOMZ!6_/M<09@CHBQ%=9IHE,:YX2"G&T%$)OOD1)F25/P&^=:YOP'J)5JXM
M0-AZF)SN;'-?L.!]J+`6NP\V+W$*MW([!]^0BMLU<MD'=?&=9[,1%3)R`QP=
M&AT.S4HJ_6>`[)TM2GM3E&-++3Z[9DH3-3?[8SH-RHB89;.PR'-FV6?0+U>3
M?N=)@')2-0=5,WW2^Q;WQBT#=0Q'#7);A2EXU^S[XAB[6'WU/!:>4\DYG@HJ
MF@]#/];$`EQE"MRY)A:&Z_@!8L0D&6(TS<Q0K@Q3BG@XF/HQ"4NT/CDWPS,Z
M#KR_=G=%15[MW:9T#7B+JPJP_!V>4\%T6`"B=V?DMJQO@$3Y@XB8';&%L1Y_
M@GFC7J_A3<W'THN'VI,HC&\]8[M(J\S[AJ2QUDS#FA$[$XJD<ESD;P2^(BH0
MC_3/K<!QS8]6X"-R2?\!OQGEDD_RR<7?Z8M)[3^<&;T?BW[HE\/QE,'/=?5Z
MQ,E\K$6!$D60\<'/7\)2?KG?L)L8[H."0BEX"H6HQ/_4X+/+_I-@Y[6_$3U.
M9`3(-6'R3W)`>.L8[-@4'L1%1_U@-W@GW/!7%I$I[;WG#ZX"S_G+JZ!E?V<5
M^'WQ_7*Q7/P?'P!,HPT*96YD<W1R96%M#0H-"F5N9&]B:@T*#0HQ(#`@;V)J
M#0H\/`T*+T-O;G1E;G1S(%L@,B`P(%(@70T*+TUE9&EA0F]X(%L@,"`P(#8Q
M,B`W.3(@70T*+U!A<F5N="`T(#`@4@T*+U)E<V]U<F-E<R`\/`T*+T9O;G0@
M/#P-"B]&86)C,2`Q,"`P(%(-"B]&86)C,3(@.2`P(%(-"B]&86)C,B`Q,B`P
M(%(-"B]&86)C,R`Q,2`P(%(-"CX^#0HO4')O8U-E="!;("]01$8-"B]497AT
M#0HO26UA9V5"#0HO26UA9V5##0HO26UA9V5)(%T-"CX^#0HO5'EP92`O4&%G
M90T*/CX-"F5N9&]B:@T*#0HR(#`@;V)J#0H\/`T*+T9I;'1E<B`O1FQA=&5$
M96-O9&4-"B],96YG=&@@,S`S-@T*/CX-"G-T<F5A;0T*>)SM7-USW+81?]?,
M_0]XZ(,ZH[#X_GBKXR:I.T[36)II9IH^4#R<Q)A'GOFAR_6O[P(D0"J1%%D^
M7,:=CB.;U)'`[F+WM[]=X/+E#ZNS#ZLSG$FBE$;8_9FNJ<R4Y)PCBC.AI52H
MV*[.*&+&9$Q*0Y#!&&G,46M79_]$]>J,(/>GO?&/:>,?,(1/C[O'-GXZ/\CX
M*5Y^Z@?Y\FIU]J>O\^N"4$0DNH)7O%A^7.*O8!;XC`CX%$0R(J,:"X6N_N,T
M(5J#]%?[U=GYJ^MFZ-&KHCU<-IL_HJN?5F=?P>C??Z00Y#$A"/Q-)!^E4!D3
MAC`OQ?F/5,B73_BHUD3/:I^C!!/0I5U!(\YGNV()GWJ[OJG[-F^*H<I;]-;6
MG>U>*`IR]GI0$LJ=JI)^FJJ_X4!,C(K2#'0C9ERZ5U71U$>?SZL3YF.9YDSS
MX"J4'GTZP1;3R8QC@B?/[(YO2[F<C&=84RPF6SX0>N/[[[YQ$_]M=?8O]&^X
M7:_.),N$&X?"/S`07,WWU>KL\N-D?3QFN?OA`3FD80XM'HS9QR2%][UH'$^B
M4C+??[RH3P?C9-=?A,"CHE%ZWXI4?(H5'Q=-+I:<9(QPPR><8%SQ$2;*!4Q4
MOX:)QW60]W2@5*?0@5*ST`&63B@J@@[&&#8J@?+6HO[6HFW3]6C3V@^#K?OJ
M@,KMKLKKWJXGW5!9^^?V35NM+]"^[&_A'?]R7B.89UM65=G4X<4.=65=^+'+
M-A'`D0APG$K*@G:8&C$O4;,>BMX+-BI@\Q;4(\;@+ON1<NQ^TH`BY4LATZ,B
MY6HQ'PQ!L3:342A5[KV]A\A/HPR/HP_#+@W09Z'/,11F1,X*)\BB8,"%04FF
MJ"8Z>)D@8O*R-]^][5"SV=@6%7F?MWG1HUW>E]9%08[N\K:T_0&>0->VMIL2
M?@M!TZ.;\LX^^,9FJ"K4YO6-=2]]&/*JA/>3Q!`V,8:(Q#2B'""'&;6[*SN(
MGA@J5Q!"J?R',+>>^&3^XQ)EM$`*%N9H4;2PR("Z\Q"00*R#^WQ_D<RBE/*3
M6I0RFM2BU'E(M"C+E)(J0AS7(:M=-6U9H+Q>IX,Z;DYJ6`:%2DK#,DD6AE69
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M\/+Z)E;/H9S.T-=AA#1!*+373ZN,*FE&#R$9)DK'OH73+O<QZ,A]GT`0USH.
MD@#\&T4G2Y_O]_LL'T,>[-4W;58TVV?VI5P#"H;E4^-$B/G^B(T3ESF"[.=9
MBBXTC$])B"HNF`RM"\`0+9;-_=>A.KP<VAO;'M*X#":1I410@3RMN`S"S&5J
MZ0K4XXN!V2R'YF`4PV7D)RS!?&8QG\FH%HJ,\Q55,ZPA<H\_IS!/Z,B//Y\4
M\WPI$I)<Z./@5!D2.HS42#W58E.:MP=[?$"G>B'!"1IL;.&EP'(T52IV'04G
M++#:.N^'-J\\^%^@_6U9W,),W5#UOH]Z70V0']8($L':;IIBZ.#F%WV66!C,
MC=CUT+J,<G2UE"]59A`@3.N@%G5[9*-:$0*Z![#H,="&L0&=#?`5C]F:RWA[
M/,C6OI8+"BSW@T`!K<RTKX?Z)DG.-3IZ(*-<Q!B0"D\SMQ;6<*+>4Y\O@2#W
M)$D="X2JY71<:4/FQ"'40Z$PMCT=G[JVMH;YMLW=[->36V4QZ760=>JZZ>%I
M1Z[NK(\"U]4)FQ:5S1U4PW,00KZ@:"V\?%VE(5=&QM"76)K@8IR8D"BOJ[)>
MU[;KQGV2?;FV,:(C[SL!`6-8SM+R3"H]2>OY5XCD8/'G,C`8U46OF(*92QYO
MCQ?,CG0$T1/1+Q.V*&`$KE4,6"KQ/?:5IA?C!`B-"<B:S&6QD#6U8R'[L$U_
M@=[41>8H5]QY2\!*V"S."6`#B'6<#F<8AZZ0,H;J`!HAKH^?P0F?IY<9)5*'
M"I`(PJ8$#EP%(*6USPH*ZK?+0::I*I'S[1&+$A<4L]-H,>]#83:9#:K.[2ZO
M#]/F;)=7MO.UZ6[7-C^7`#BV.J`_0!V/KL->;8THQBI#<1,TL)4(TFN[+@$O
M`'@A>Z9J'6D=53,*S[D;XF%*),WN%I)'M2T+$'H]='U[\*6XQ.A@\Q98%O`K
MN"AN+5RO(5E4S0ZNMGD];`#J!OC8IXYMWKZWD%IVMSE@<&&''M2KX$D'ANX2
MV0]#N=M"LO'/PU!EX<8$X_2._?A$EL0(,D:A@&0:_!+J4<X"`X/LT375X%+'
MJ$X#2]).W-'[+)I:@%.R]0D1K4NP3><M4W9-N[;M\FW0;%V.0\YD/4N$?E+K
MI::I\<9EZ3@=R0PCL>7#&8Z$?9O_U+1ND[4#M["W304F<KB;9)WGXSD":QJZ
MN$09.3G[WVW75S\R02Y\US9[E5TDS0`+F4Z1`=0\':P(ES.624TB<:QR("?N
M3$K3K`.T+9IG)R!1P&]F2:%>QWK1PG+!\6SB-#(E'4Y4"4GC[?%RA)`LBOMB
MXO3XD44AYW5[:3?A:5JFL?*CN\.8VL5"L3K[(MXXKWB=>^A#KYNZL&WM*`(X
MQ#YO7Q@53\A#%P+=CXHO$LRE[BG/W!'5H+R_<<J_;9KW3N/+'M*QRT]=]L)E
M8$_M,^LH"DR/!=/4RQ*O_?[Z+6"CZW=W,'KE4@L@Z&%,D<`I-I^R)D\()PD^
M[IH\.9=8K`F64I"P)M.-,T0UK4D7U\23K^FHV=;FWD<AJQY=/G!/I:-X4)G1
M*-YXX\1S0ORC+>]`.'1I"ZBS^Q)XT%OXYV:$SG?6P2AZ5?C-9V(@*<5#<?4A
MV4IRCJ/XJ5?2-;`6IM*>1T^F&F\\>WY@*5N[J2Q8QIGQKK1[SX^:H76L,K^Q
M(T>,I"G)$LLH-U%Z]L#QQLF]=FOK)?A52/HR`'ZS\SHT:#,X&HQ\(Z6+?93K
MW'4?P17RKANVNYE:=L/U3].;;=F]'W\Y..!U0>X<*4/?E#"8T[Y+I#^?H8@3
M*0,4C==._WL"7:!#,P"':X9JC5SG:&R[#5`Q6&>6,G<;X$V0.)UWRRAY<N\&
M*`IS@6&44#,0C#</XU2&OOJYL+L^E'7VY]ZYLSL`7+K>--@,*+#[9&/A"NJB
M).M+Y_4E[@S%M+[CM2>",VQ5^7YT0B=5.U131=?:FZ'*1[^%XF<[5#>^7KT^
M^`<7N.>>!JUO_<G*U\UV6W:N;H*:UX[Z]OE["WZ#FNLJ`.2+>\:_H?@BQQ*F
M9L59.%Z^&T"(`BKV83?&>`N3`-.UH,9APIR$/LQ`0'6B7,L6!G$\PYWR"SX\
MWCSLPZY987T)ZS!J`NO:[N\5!V"W^\`'ORC*MABV,!#`P4N+O*?75^IY?9ER
MC:5Q?<=KW]%HQ_)[#TOZ0K;^-)V6;J;1HAB[39S)HN.-$^%;NRYS]*9V(0_Q
ML3PJ]+_Z,QKZ_/<6XS-2^TU]Y\]IS'YR]-(2\E3TUC1?AI.$Q7!4S(@0CN.U
MBX6_-A5@[>LJ;]__WHOU&3C%Y_QS!+7_T@PWZ-N\^&O>]Y_0(WTT'BB.'ILF
M'H291M<8)SA+'L?'F9SXZ$MIPU/]N84>DI$$9VY/HX=:Z(&-I+]W@'QFP?@Y
M_CQ3[131*4\5GG(9GSR%)J<*4+F,4"V,.3[B8S[/D`;Q%8N[QS2<.[QUI"<K
M'.GYL]_1J/+K[OD'<MTNAI!F^BZVXO'VB%_%5B**_G^4^#Q_$GP;AI#9H=W_
MDF$Z>W:^!F*6;?/BUA.S%_@TC+QT:HW52YWZB?Z`TL+W[4*_PT@S0M?'[RS"
M4"`:Y^%\I5;Q-LKKOROOMMTU3,X?MO1CWP'1VGTM+X(L'2NG\U\O*_SWU0^K
ML]79?P&=(<(_#0IE;F1S=')E86T-"@T*96YD;V)J#0H-"C,@,"!O8FH-"CP\
M#0HO5'EP92`O3W5T;&EN97,-"CX^#0IE;F1O8FH-"@T*-"`P(&]B:@T*/#P-
M"B]#;W5N="`R#0HO2VED<R!;(#@@,"!2(#$@,"!2(%T-"B]4>7!E("]086=E
M<PT*/CX-"F5N9&]B:@T*#0IX<F5F#0HP(#4-"C`P,#`P,#`P,#`@-C4U,S4@
M9@T*,#`P,#`R-S(Q."`P,#`P,"!N#0HP,#`P,#(W-#8W(#`P,#`P(&X-"C`P
M,#`P,S`U.#D@,#`P,#`@;@T*,#`P,#`S,#8S,R`P,#`P,"!N#0IT<F%I;&5R
J#0H\/`T*+U-I>F4@-0T*/CX-"G-T87)T>')E9@T*,3@S#0HE)45/1@T*
`
end
</PDF>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
